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ABSTRACT 
Background 
Although curable, tuberculosis (TB) remains a serious health care problem. During 2011 there 
were almost 9 million new cases and 1.4 million TB deaths worldwide. The World Health 
Organisation (WHO) lists South Africa as a country with a high TB, HIV and MDR-TB burden. 
In this country the dual TB/HIV epidemic which has reached critical proportions is fuelled by 
the high TB/HIV co-infection rate.  
By definition the focus of palliative care is on the alleviation of suffering associated with life-
limiting illnesses. TB clearly falls into this category. The palliative care-related outcomes of a 
cohort of hospitalized TB patients were determined during this prospective longitudinal study 
and a quality improvement strategy was then generated from the audit data.  
Methods 
The APCA POS, a validated outcome measurement tool was used to conduct weekly 
interviews. The audit sample comprised 57 patients with MDR-TB and 57 with drug responsive 
TB (n=114). The intensity of the multi-dimensional palliative care-related problems experienced 
by TB and MDR-TB patients on admission as well as the differences that occurred over time 
were measured over four consecutive weeks. 
In order to get staff perspectives on using the audit data to develop a quality improvement 
strategy, a report on the analyzed audit data formed the basis of a focus group discussion 
(FGD). The purposive sample of FGD participants included key members of staff from the TB 
and MDR TB wards. 
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Results 
Audit findings indicated that on admission to hospital the predominant problems were pain, 
symptoms and worry. On a Lickert scale of 0-5 with 0 indicating best and 5 worst, the median 
score for both pain and other symptoms was 3.0, with an inter-quartile range of 2.00-4.25.  
Participants’ worry about their illness attained the worst median baseline score of 4.0. Neither 
pain nor symptoms showed any sustained improvement over the four weeks of data collection. 
A statistically significant improvement in worry which moved from 4.0 to 2.0 occurred after 
week 1 but then remained static. An unexpected crucial finding was that the collective score for 
participants with drug responsive TB was worse than for those with MDR-TB for both the 
physical and psycho-social components, and at each time point. Using the APCA POS audit 
data as the basis of a FGD with key staff members resulted in the development of an 
appropriate palliative care-focused quality improvement strategy which they considered to be 
realistic and achievable within their busy hospital setting. 
Conclusion 
Findings from this study support the recent WHO Declaration on the provision of palliative care 
for people with drug-resistant TB. Furthermore they clearly show that patients with drug 
responsive TB should not be excluded from a comprehensive palliative care person-centred 
approach. Palliative care within the context of TB is still an emerging concept. This study 
makes a meaningful contribution to the scarce information currently available. The topic is 
important in that the suffering experienced by vast numbers of TB patients and their families 
could and should be substantially relieved.  It is suggested that it would be valuable to explore 
the impact of a palliative care approach on TB treatment outcomes.  
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CHAPTER 1          INTRODUCTION 
___________________________________________________________________________ 
INTRODUCTION 
This study was prompted by the magnitude of the tuberculosis (TB) epidemic in South Africa 
and around the world, in terms of the following: 
 Sheer size of the problem 
  HIV/TB co-infection rate 
 Increase in drug-resistant TB  
 High burden of symptoms experienced by TB patients 
 Poor cure rate  
 Substantial mortality rate associated with drug-resistant TB 
 Need for palliative care within the context of TB 1-5 
 
Background 
In order to halt and reverse the TB epidemic, in 1993, the World Health Organisation (WHO) 
declared TB to be a global public health emergency and in 2000, the United Nations Millenium 
Development Goals (MDGs) adopted by all nations included global TB health care targets 
aimed at halving the incidence, prevalence and deaths from this disease by 2015.1 The latest  
WHO report states that the global MDG TB health targets have already been achieved but 
warns that “global progress also conceals regional variations” and the African and Eastern 
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European Regions are not on track to halve 1990 mortality levels by 2015.2 The HIV/TB co-
infection rate is largely responsible for this unfortunate scenario, almost 80% of the HIV 
infected people with TB in the world live in Africa.3,6  TB remains a serious health problem. 
During 2011 there were almost 9 million new cases reported and 1.4 million TB deaths 
worldwide.2  
Progress in responding to drug-resistant TB remains slow and the number of MDR-TB cases in 
the 27 WHO high-burden countries is increasing and reached almost 60 000 in 2011.2,7   
Extensively drug resistant tuberculosis (XDR-TB) has been reported by 84 countries and 
accounts for an average of 9% of people with MDR-TB.2,4,8  Every year tuberculosis still takes a 
huge toll in terms of unnecessary deaths, especially for poor and vulnerable people who are 
most at risk and have the least access to quality health care.9 
WHO lists South Africa as a country with a High TB Burden, High HIV Burden and High MDR-
TB Burden, the 27 high-burden countries currently account for over 80% of the world’s TB 
cases. The 2012 WHO Global Tuberculosis report states that India, China, the Russian 
Federation and South Africa have almost 60% of the world’s cases of MDR-TB. Overall, the 
African Region carries 24% of the global TB burden and has the highest rates of cases and 
deaths per capita. In 2011 the population in South Africa was estimated at 50 million with a TB 
incidence of 993 per 100 000. This figure includes 5000 new and 3100 retreatment MDR-TB 
cases with 65% of the TB patients in whom HIV status was known co-infected with HIV.2   
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Study summary 
This study was divided into two phases. A measurement of the palliative care –related 
problems experienced by hospitalized TB patients admitted to a rural District Hospital formed 
the focus of the first phase.  A validated outcome measurement tool, the APCA (African 
Palliative Care Association) African POS (Palliative Outcome Scale) was used for this purpose. 
The APCA POS was rigorously validated and found to be suitable for use within the resource-
constrained African context. This brief multi-dimensional outcome measure uses patient and 
family-level indicators that could be used in the routine clinical practice of palliative care. The 
tool is simple and easy to use and was developed so that it could be applied so that the quality 
of care provided could form part of a continuous improvement strategy that could be used to 
inform daily practice. Because of varying levels of literacy in Africa, the APCA POS is 
administered by a health care worker.10, 11  
The prevalence and intensity of the multi-dimensional physical, social, emotional and spiritual 
problems of hospitalized TB patients in a rural District Hospital in KwaZulu-Natal were 
identified and measured on a weekly basis for four consecutive weeks. Data was collected on 
a weekly basis. The first interview took place on a Tuesday and included participants admitted 
to the hospital on that day or during the previous 7 days. The following three interviews were 
conducted on consecutive Tuesdays for the following three weeks. The vast majority of the 
audit interviews were conducted in isiZulu by the research assistant, an experienced Zulu-
speaking palliative care trained professional nurse.   
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Phase 1 findings 
Audit findings indicated that the predominant problems experienced by participants on 
admission to hospital were pain, symptoms and worry. For both pain and symptoms, on a 
Lickert scale of 0-5 with 0 indicating best and 5 worst, the median score was 3.0, with an inter-
quartile range of 2.00-4.25.  The question regarding worry about their illness attained the worst 
median baseline score of 4.0. Neither pain nor symptoms showed any sustained improvement 
over the four weeks of data collection. Worry did show a statistically significant improvement 
after week 1 but then no further change.   
An unexpected finding was that the scores for participants with drug responsive TB were 
worse than for those with MDR-TB with regard to both the physical and psycho-social 
components at each time point. Almost three times as many deaths occurred in this patient 
population. This finding does, however, need to be considered within the context of drug 
responsive TB being predominantly managed in the community. As a result only patients with 
advanced illness or severe problems are admitted to hospital. 
Phase 2 findings  
During the second phase of the study, data obtained from this audit of 114 TB patients, half of 
whom (57) were diagnosed with MDR-TB and half with drug responsive TB, were reviewed 
bkey staff members in a focus group discussion (FGD). The FGD participants used the audit 
findings, particularly the predominant problems of pain, symptoms and worry to generate an 
appropriate palliative care-focused quality improvement strategy.   
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Importance of this study 
Palliative care within the context of TB is still an emerging concept. It is hoped that this study 
will make a meaningful contribution to the scarce information currently available on a topic of 
great importance that could substantially relieve the suffering experienced by vast numbers of 
TB and MDR-TB patients and their families. 5   It is the first study to demonstrate the palliative 
care-related needs and outcomes of this patient population. As such it has responded to the 
urgent call in the literature.10, 12, 17, 52, 64   By including the development of a quality improvement 
strategy within the context of TB, it will support the existing Guidelines for Providing Palliative 
Care to Patients with Tuberculosis. These guidelines have r cently been translated into 
Portuguese and French.5 
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CHAPTER 2                                                                        LITERATURE REVIEW 
  
 
LITERATURE REVIEW 
Perceptions about palliative care for people with tuberculosis 
Because the provision of palliative care for people with TB is still in an early developmental 
phase, no studies on the specific subject of this research were located. Several publications 
that mention the term palliative care in relation to TB were reviewed. 12-15    
 
Palliative care at the end of life 
Authors of these articles mentioned in the paragraph above all acknowledge the value of 
palliative care at the end of life when curative treatment has been shown to be futile. Harding 
et al focus on the life-threatening nature of MDR and XDR-TB and describe the ‘burden of 
disease management in terms of symptoms, adverse treatment effects, adherence, stigma and 
subsequent discrimination and social isolation’ to demonstrate the need for holistic care. They 
assert that to date the relief of suffering has, for the most part, been restricted to physical 
aspects. The existing WHO definition of palliative care is appropriate for patients with drug-
resistant TB in that it aims to improve the quality of life for individuals as well as their families, 
and advocates for palliative care alongside treatment.21  
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It is proposed that the WHO definition allows for the provision of palliative care to patients with 
drug-resistant TB from the point of diagnosis to eventual cure or death.12 After drawing 
attention to the fact that the prognosis of XDR-TB patients can range from several weeks to 
years, Dheda and Migliori suggest that because of the lack of palliative care facilities patients 
are unable to die with dignity, in particular those for whom there are no further therapeutic 
options. They suggest that priority should be given to building ‘palliative care treatment 
facilities’ that would prioritize infection control and function like the sanatoria that existed prior 
to the availability of effective TB treatment.13 The terminology ‘embracing palliative care’ is 
used by Upshar et al as an endorsement of the palliative care mantra that withdrawing futile 
treatment does not mean withdrawing care and actually indicates the need for care to increase 
and include meticulous attention to the control of pain and other symptoms. They advocate for 
palliative care to be offered to all XDR-TB patients who no longer qualify for active treatment 
so that they are permitted to live their lives out with minimal suffering and loss of dignity.14  
 
Palliative care throughout the disease trajectory 
The apparent focus of the literature on end-of-life care may be attributed to the fact that 
modern palliative care was introduced fairly recently and initially focused on the provision of 
end-of-life care 16, and that perceptions about palliative care being limited to care of the dying 
have not yet substantially changed. In welcoming the WHO declaration regarding the 
systematic inclusion of competent palliative care services in TB treatment programmes, 
Connor et al suggest that current TB policy and strategy should make a more explicit reference 
to palliative care.17 Palliative care has always been comprehensive in the approach to patients. 
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It was initially focused on dying cancer patients but has gradually broadened its scope to 
include other life threatening diseases including AIDS.17, 18   Co-infection of TB and HIV as well 
as the rise in drug-resistant TB and its high mortality has highlighted the need for palliative 
care for this patient population. 6,12 ,13  Abiding by the principle of impeccable management of 
holistic patient and family needs is as applicable to end-of life care as to palliative care which is 
provided early in the disease process. Furthermore, palliative care may continue to be 
provided throughout an extended course of a chronic life-threatening disease, regardless of 
the prognosis.13, 16, 18  The control of pain and other distressing symptoms along with an 
accompanying emphasis on the quality of life, the value of life and the meaning of life are the 
hallmark of palliative care throughout the disease trajectory.19,20  This is in alignment with 
definitions of palliative care by the WHO and the Worldwide Palliative Care Alliance which both 
state that it is applicable from the time of diagnosis and throughout the course of any life 
threatening illness.21, 18   
 
Palliative care improving survival outcomes 
Although the focus of palliative care is about adding life to the remaining days rather than days 
to the remaining life, practitioners have long held the anecdotal opinion that this holistic 
approach to care contributes to improved outcomes in terms of survival. A recent study 
conducted by Temel et al in the United States which demonstrated that in addition to better 
quality of life, the median survival was longer among patients with metastatic non-small-cell 
lung cancer who received early palliative care than those receiving standard care, supports 
this notion.22 
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Comparable aspects of palliative care for HIV/AIDS and TB 
A systematic review by Harding et al23 to appraise the effect of models of palliative care on 
patient outcomes utilised data from published papers involving 34 services. Their study 
demonstrated that patients with HIV infection require palliative care throughout the disease 
trajectory in order to control pain and symptoms, promote treatment adherence and manage 
the side effects of treatment. They reached this conclusion because of the following five key 
factors: 
1. The mortality rate of HIV infected patients including those on highly active antiretroviral 
treatment (HAART) continues to be higher than in the uninfected.  
2. HAART is associated serious side effects such as peripheral neuropathy. 
3. New co-morbidities such as end stage liver disease secondary to hepatitis, myocardial 
infarction and various neurological disorders have come about due to a longer prognosis. 
4. Some HIV-related carcinomas including cancer of the cervix have not declined in incidence 
with HAART. 
5. Many HIV infected people do not know their status and only present with advanced 
disease. 23  
 
The need for holistic care 
In another review the same authors made the pivotal point that “optimal care for those with HIV 
disease continues to be a priority alongside prevention and treatment, and the provision of 
HIV/AIDS medical care focusing on the purely technical elements of HAART would be 
detrimental to both patients and carers”.24   In their protocol for a study currently underway in 
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Kenya and South Africa, Lowther et al reiterate this concept by suggesting that effective 
treatment for the virus might not be enough to alleviate the suffering experienced by HIV 
infected people.25  They based this statement on findings of studies conducted in Brazil, 26 the 
United States,27  South Africa28 and Malawi.29   
There is a strong case for assuming that these findings related to HIV infection would be 
mirrored in respect of TB. This assumption is strengthened by the high HIV/TB co-infection 
rate and the fact that TB remains the leading cause of death in HIV infected patients in South 
Africa and at 53%, the highest number of TB deaths, are attributable to HIV.3   In addition to the 
pain and symptoms associated with the disease process of tuberculosis which is often 
exacerbated by HIV co-infection, distressing side effects of treatment have been documented.  
 
Side effects of TB treatment  
In a retrospective record review of a substantial sample of 350 outpatients at the MDR-TB 
clinic King George V Hospital in Durban, Jacobs and Ross reported adverse events in 80.6% 
of the patients. These included hearing loss (28.7%); peripheral neuropathy (23.2%); 
diarrhoea, nausea and vomiting (20.5%); rashes and dermatological effects (other than 
Stevens-Johnson syndrome, (no reason was given for the exclusion of Stevens-Johnson 
syndrome) (14%); abdominal pain and dyspepsia (10.3%); and psychoses and confusion 
(8.3%).30   An HIV/TB co-infection rate of 74.5% was reported in this study in KwaZulu-Natal 
where the estimated provincial HIV prevalence in the general population was 24.9% in 2010.  
In keeping with Harding’s finding, there was no statistically significant difference in the 
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development of adverse events in HIV+ patients who were on HAART and those who were 
not.24, 25    
Although treatment of the side effects was not included in the record review, it can be 
extrapolated from the findings that effective symptom control related to the side effects of 
treatment would be beneficial to MDR-TB patients. Additionally, if these patients were offered 
palliative care they would be likely to benefit from an overall improved quality of life.5,18 
 
Focus of TB literature 
The bulk of the current TB literature focuses on treatment outcomes and how these can best 
be attained. This is in line with what Harding et al referred to as the ‘purely technical aspects of 
HAART’ in relation to the treatment of HIV infection.24  In general, scant attention has been 
given to the person with tuberculosis and how the disease and treatment is affecting his/her 
quality of life and that of the person’s family.31,32   There are, however, a number of exceptions, 
Yew et al acknowledge that psychosocial support is an important element in the management 
of adverse events and that education, counseling and encouragement can all contribute 
towards achieving successful patient outcomes in terms of treatment adherence.33   In a US 
study published in 2009 Miller et al made the point that people who are cured of TB are ‘left 
with lifetime sequelae that substantially reduce their quality of life’.34  These consequences of 
TB are likely to be exacerbated in the resource-constrained African setting where large 
numbers of vulnerable people do not have access to affordable services of sufficient quality.9  
This view is echoed by Hanson et al who refer to the enormous direct and indirect costs 
associated with tuberculosis in terms of the social consequences for the individual patient, 
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family and community.35 ,36   An Indonesian study which investigated the social aspects of 
patients with pulmonary tuberculosis found that socio-economic constraints and social 
problems were serious and common. They recommended that priority should be given to 
developing programmes aimed at providing family support.37  
All the psycho-social aspects mentioned by the authors cited in the previous paragraph 
resonate with the practice of palliative care, in concert with the resolution of pain and other 
distressing physical symptoms.38, 39 
 
Value of care in terms of TB treatment outcomes 
It is important to note that these ‘soft’ issues are important both in terms of patient care and 
disease outcomes within the context of TB. This was demonstrated by an MDR-TB programme 
run by Medecins Sans Frontiers in Khayelitsha in which a patient-centred decentralized model 
of care increased case finding and improved treatment outcomes thereby reducing further 
MDR-TB transmission.40     
 
Using audit results to improve the quality of palliative care 
In keeping with Crombie et al’s definition of audit as the process of reviewing the delivery of 
care to identify deficiencies so that they may be remedied 41 the second phase of this study is 
focused on using audit results to develop a strategy to improve the quality of palliative care. 
According to Selman and Harding clinical audit is a cyclical activity. The first phase involves 
the identification of areas that need improvement by analyzing data obtained from the 
administration of an appropriate and validated questionnaire. This should be followed by 
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setting measurable quality of care targets in specific areas, designing and implementing quality  
improvement strategies and then re-evaluating the quality of care using the same 
questionnaire to assess progress in meeting the targets.42  Generically, quality of health care 
has been described as the extent to which health services provided to patients improve 
desired health outcomes.43  
 
Outcomes 
Outcomes can be understood as any end result that can be attributed to a targeted health 
intervention.42, 43   Making use of a patient outcome scale is relevant because it measures the 
results of care directly, as experienced by patients.42 Measures of quality of care and patient or 
family satisfaction have increased in use over the last two decades. According to Heyland et al 
in the field of palliative care, however, lack of valid and reliable measures makes their use 
uncommon.44  The goals of palliative care include improving health-related quality of life as well 
as spirituality, coping with loss and grief and family involvement, it follows that palliative care 
outcome measures need to reflect this.45  
 
Palliative care outcome measures 
In 1986 Higginson and her colleagues from Kings College in London headed up the 
development of the Support Team Assessment Schedule (STAS) which was constructed to 
evaluate the palliative care provided by support teams. This was the precursor to the Palliative 
Outcome Scale (POS) which was developed in 1999.46   In a systematic review undertaken by 
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Bausewein et al the point that STAS was developed for exclusive use by health care 
professionals is made. The POS, however, has a staff and patient version. A further 
development of the POS is the addition of a symptom list (POS-S). Adapted versions of POS-S 
have been used in patients with multiple sclerosis and renal failure. Both of these palliative 
care outcome measures were originally validated in patients with advanced cancer and most 
studies using STAS reflect this. The POS, however, has recently been increasingly used in 
non-cancer patients and there are plans to develop a modular system with different symptom 
lists adapted for different conditions.47  In a study examining the internal factor structure of the 
POS, Siegert et al concluded that the POS appears to capture emotional status and quality of 
care as well as three items that function independently namely family anxiety, symptoms and 
pain control.48  Together with colleagues from Columbia University, Krug conducted a study to 
compare the self-assessments of late-stage HIV/AIDS patients regarding their symptomatology 
and sense of self-worth, to assessments completed by their informal caregivers. They found 
that there was substantial to moderate agreement to four items assessing physical and 
emotional status and only fair to slight agreement to the remainder, including those assessing 
the patient’s sense of self-worth, family/friends’ anxiety, interactions with family/friends and 
practical matters. These findings underscore the importance of assessing patient care 
outcomes directly and suggest that more effective communication about relevant health issues 
among seriously ill patients and their informal caregivers and health care providers is 
needed.49 This was echoed by Stevens et al in an earlier study which found that at the initial 
assessment, staff underestimated patients’ pain and overestimated problems related to 
information giving and patients’ ability to share their feelings.50  In a challenging article in which 
Baldwin et al describe the impact of the social media on patient empowerment, they argue for 
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the inclusion of a separate definition for patient reported information and describe how this 
differs from patient reported outcomes. They suggest that these new emergent data from the 
social web have important implications for decision making as well as for changing the 
relationships between health care providers and patients.51 Social media is already having an 
impact on health in the developed world and is probably poised to do the same in Africa.  
 
Measuring palliative care outcomes in sub-Saharan Africa 
In an appraisal of the status of palliative care in Africa conducted on behalf of the Diana 
Princess of Wales Memorial Fund in 2004, Harding and Higginson stated that for the 
overwhelming  majority of Africans who currently endured cancer, HIV/AIDS  and other life-
limiting diseases, access to culturally appropriate holistic palliative care that included effective 
pain management was ‘at best limited and at worst nonexistent.52  Not surprisingly the need for 
increasing the access and coverage of palliative care without comprising on quality was 
identified as a primary concern among palliative care practitioners in the region.11   However, 
measuring the actual quality of care provided was problematic without having rigorously 
validated outcome measures that reflected the disease profile on the continent and were 
suitable for use within the resource-constrained and culturally different African context. The 
focus of the POS which was widely used in the first world was on measuring the patients 
physical symptoms, psychological, emotional and spiritual needs, and the provision of 
information and support at the end of life.53,54   The APCA POS, a brief multi-dimensional 
outcome measure using patient and family-level indicators that could be used in the routine 
clinical practice of palliative care was developed specifically for use in the African context.10,  
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This tool was developed under the auspices of APCA by a multi-professional expert group that 
included appropriately experienced local and international palliative care practitioners including 
two from South Africa. It was informed by but significantly adapted from the original POS.46   
The group deemed it important for a palliative care measurement tool for use in Africa to be 
locally validated, appropriate for both cancer and HIV infected patients and to be relevant 
across the disease trajectory.42   While scientific principles underpinning palliative care 
outcome measurement are transferable it is essential that outcome measures reflect the 
prevailing illnesses and culture. 55  
 
Validation of the APCA POS 
The study which subsequently validated the APCA POS and had it translated into 8 different 
languages, including isiZulu,  concluded that it had sound psychometric properties, was well 
comprehended, and brief and easy to use. Owing to the varying levels of patient and family 
literacy in Africa, the APCA POS is completed by a member of staff.10,11  All answers are 
scored using Likert scales from 0-5, with numerical and descriptive labels. The items address 
physical and psychological symptoms, spiritual and emotional concerns as well as 
psychosocial needs. The APCA POS measures the key domains of palliative care which 
include pain and symptom relief, emotional/spiritual support and grief counseling, support for 
family caregivers and advanced care planning.10, 11   It was necessary for the tool to be simple 
and easy to use so that progress achieved in the quality of care provided could form part of a 
continuous improvement strategy that could be used to inform daily practice.56 
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Linking audit findings to quality improvement 
According to Scally and Donaldson, a commitment to deliver high quality care should be at the 
heart of everyday clinical practice.57   In terms of the clinical audit cycle described above 
setting targets for quality improvement is the step which follows the gathering of patient 
outcome data.42   Dunckley et al endorse the value of clinical audit in providing an evidence 
base for service development and emphasise its importance in resource-limited settings where 
it is essential that limited health care resources are used in an effective and efficient way. Their 
study identified a top-down approach, time constraints, limited access to resources for data 
analysis, perception of irrelevance to practice and lack of knowledge about the importance of 
outcome measures, as barriers to their routine implementation. Participative management, use 
of a brief outcome measure at an appropriate (not too often) frequency, linkage to a research 
resource and staff training were identified as facilitators.58   In similar vein Johnston et al 
suggest that whilst clinical audit could provide valuable assistance to programmes aiming to 
improve the quality of health care delivery, it is necessary to address the concerns of the 
professionals involved.59   
 
Organisational factors that affect quality improvement initiatives 
The Council for Health Service Accreditation of Southern Africa (Cohsasa) decrees that the 
quality improvement process should be consistent with the organisations’ mission and plans; 
meet the needs of patients, families, staff and others; and make use of current clinical practice 
guidelines and other relevant evidence-based information. The use of a validated audit tool to 
improve the quality of care has been included as a criterion in the Quality Management and 
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Improvement service element in the second edition of the Hospice Palliative Care Standards.60 
According to Walshe and Freeman the organisational context is a crucial determinant of the 
effectiveness of quality improvement initiatives. Some organizational cultures seem to provide 
fertile ground for quality improvement because of a fit with their organizational values whilst 
others simply do not.61-63 One of the reasons for selecting Murchison Hospital as the site for 
this research is that the facility is committed to the provision of quality care and actually lists 
commitment to performance and quality improvement as one of its core values. In 2002, this 
260-bed hospital was the first KwaZulu-Natal hospital to achieve Cohsasa accreditation at its 
first attempt. It is therefore anticipated that the organisational culture will be conducive to 
quality improvement. 
 
Importance of this study 
This is the first study to report the needs and outcomes of this patient population in response 
to the urgent call in the literature. 12, 17, 52, 64   By including the development of a quality 
improvement strategy within the context of TB it will support the existing Guidelines for 
Providing Palliative Care to Patients with Tuberculosis.  These guidelines have recently been 
translated into Portuguese and French.5 
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AIM 
The aim of this study is to determine the palliative care outcomes of a cohort of hospitalized TB 
patients, and to generate a quality improvement strategy from the data. 
 
OBJECTIVES: 
1. To measure the prevalence and intensity of multi-dimensional problems among TB patients 
on admission to the hospital TB and MDR-TB wards 
2. To conduct an audit of palliative care outcomes for study participants to determine whether 
there is a difference in the prevalence and intensity in the problems experienced between 
TB and MDR-TB  patients on entry to the hospital 
3. To measure change in problem intensity over time (4 x weekly interviews) 
4. To convene a quality improvement focus group discussion with key members of staff 
selected from the TB care sites in order to use the data from objectives 1-3 to generate a 
quality improvement strategy 
5. To report on the development of a palliative care-related quality improvement strategy.  
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CHAPTER 3          METHODOLOGY 
___________________________________________________________________________ 
 
 METHODOLOGY 
 
STUDY DESIGN 
This is a multiple methods prospective longitudinal study.  The quantitative data obtained from 
auditing the palliative care-related needs and problems of a cohort of hospitalised TB patients 
was used to develop a quality improvement strategy.  
The study was divided into two phases. The first phase of the study dealt with the 
determination of the palliative care-related outcomes in a cohort of TB patients. This was 
linked to the second phase during which qualitative data was collected via a focus group 
discussion with key staff members from the TB care sites. The aim of phase two was the 
generation of a palliative care-related quality improvement strategy based upon the audit 
findings. 
In this chapter the methods related to each phase will be reported separately. 
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PHASE 1: 
AUDIT OF THE PALLIATIVE CARE-RELATED PROBLEMS EXPERIENCED BY A COHORT 
OF HOSPITALISED TB PATIENTS 
OBJECTIVES: 
1. To measure the prevalence and intensity of multi-dimensional problems among TB 
patients on admission to the hospital TB and MDR-TB wards 
2. To conduct an audit of palliative care-related outcomes for study participants to 
determine whether there is a difference in the prevalence and intensity in the problems 
experienced between TB and MDR-TB patients on entry to the hospital 
3. To measure change in problem intensity over time (4 x weekly interviews) 
 
Protocol amendments 
The following two amendments to the original protocol were approved during the sixth week of 
data collection: 
1. During weekly visits to Murchison Hospital to conduct an audit interview with 
participants who have given informed consent - collect additional data by asking the 
professional nurse in charge of each of the TB wards whether any TB patients died in 
the ward during the preceding week. 
2. Add “considered to be too ill to approach with study information” by either the 
professional nurse in charge of the ward or the researcher to the exclusion criteria for 
participation in the study. 
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The rationale for making these changes and collecting the additional data was that patients 
who had been admitted and died during the week or had been considered too ill to approach 
with study information could have benefited from palliative care.  
 
Description of study site/s  
Audit interviews were conducted at the TB and MDR-TB Wards of Murchison Hospital and two 
satellite facilities the Dunstan Farrel TB Hospital in Hibberdene and Genesis Care Centre in 
Port Shepstone, and in a few instances in the homes of participants who had been discharged. 
 On average 45 TB patients are admitted and treated in the hospital each month, 30 of these 
patients are admitted to the TB ward and 15 to the MDR-TB wards. Some of the patients from 
both sections may go back and forth to one of the two satellite facilities during the intensive 
phase of treatment. Patients are also sometimes sent straight home. The average length of 
stay in the TB ward is 22 days and in the MDR-TB ward it is 66 days. Criteria for admission to 
the TB ward include that a patient must have a confirmed diagnosis of pulmonary TB and have 
been started on first line TB treatment either in Casualty or the Outpatient Department. For 
admission to the MDR-TB ward patients have to be culture positive with a resistance to 
Izoniazid (INH) and Rifampicin. When bed availability is problematic preference is given to 
patients with social problems in both sections. 
All the wards are well ventilated. The TB ward at the hospital is rather crowded with limited 
space between beds and little opportunity for sitting outside. The male and female MDR-TB 
wards are much more spacious. There is also a roofed outdoor sitting area attached to the 
MDR-TB section with a lovely view. This was, however, hardly used by patients during the time 
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that the researchers were present as almost all the mobile MDR-TB patients gathered at the 
fence which overlooks the road in the hope of seeing a relative or friend coming to visit them. A 
number of the audit interviews were consequently conducted on this verandah which the 
researchers preferred to the wooden and not nearly as well ventilated Wendy House office 
which they were offered. The remaining MDR-TB patient interviews and all the interviews in 
the TB ward were conducted at the bedside of consenting participants. 
The Murchison and Dunstan Farrel Hospitals are state health facilities. The Genesis Care 
Centre is a faith based organization (FB0) which provides in-patient care and a Step Down 
service to Murchison and Port Shepstone Hospital, the two provincial hospitals serving the 
area. The patients who were visited at home were on the South Coast Hospice home care 
programme, the hospice is a non-Governmental organisaton (NGO),   
 
Infection control 
There was consistent evidence of the implementation of effective infection control during the 
32 weeks of data collection. Researchers were given a N95 respirator on arrival and told to put 
it on before entering the patient care section of the ward. Hand washing facilities were 
adequate and meticulous attention was paid to hygiene, particularly in the MDR-TB wards. 
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Ethical considerations  
Permission to conduct the study 
The UCT Faculty of Health Sciences Human Research Ethics Committee granted approval for 
the study on 14 May, 2012. (Appendix 1) This, together with the research proposal was given 
to the UGU District Health Manager who wrote a letter of support and forwarded the study 
proposal to the KwaZulu-Natal Research Committee. By the end of May permission to conduct 
research at the two state health care facilities, the Murchison and Dunstan Farrel Hospitals 
had been received. (Appendix 2) A letter from the CEO of the Genesis Care Centre indicated 
that the organization was willing to be included as a study site (Appendix 3).  
 
Process 
Once the required permission had been obtained to proceed with the study the following 
occurred: 
 An experienced palliative care qualified Zulu-speaking professional nurse from the local 
hospice was appointed as research assistant for this phase of the study.  
 The hospice was advised about submitting invoices so that the organisation could be 
reimbursed for her time from the study budget 
 The research assistant was given a copy of the research proposal and training which 
focused on: 
o orientation to the study design  
o sharing information via the participant information leaflet 
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o obtaining informed consent and giving participants the option to withdraw consent at 
any stage 
o completion of the data collection tool (APCA POS) using the English or isiZulu 
translation that had been done during the validation process 
o confidentiality and the allocation of study numbers in place of names on the data 
collection forms 
o the need to be continuously mindful of the need to protect and show respect to 
vulnerable participants so as to lessen the “power imbalance” that exists between a 
health care professional as the researcher and TB patient as the participant 65 
o implementation of the distress protocol. 
 In liaison with the CEO, a senior psycho-social professional at South Coast Hospice was 
approached, told about the study and agreed to her name and contact details being 
included in the distress protocol. 
Preparatory visits were then made to all the sites by the researcher and her assistant. Study 
information was shared verbally with key staff members who were also given a written copy of 
the protocol. It was agreed that Tuesday mornings would be a mutually convenient time for the 
audits to take place. Data collection duly commenced on 26 June, 2012 at Murchison Hospital. 
Privacy/confidentiality 
Participant confidentiality was safeguarded by having no personal identification information 
documented on the for 
m. Only blank questionnaires containing demographic data and the study number were in the 
possession of the research assistant.  
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Obtaining informed consent 
On arrival, a professional nurse on duty in each of the wards gave the researchers the names 
and bed numbers of new patients who had been admitted during the preceding week whom 
he/she considered well enough to approach with the study information.  She/he was asked 
how many deaths had occurred during the week and the number of new patients who were 
considered to be too ill to approach and these figures were noted by the researcher. In a few 
instances the researchers decided that a patient whose name they had been given was too ill 
to be disturbed and that person was not given the study information. All potential participants 
who met the inclusion criteria were assured that learning about the study was voluntary and 
that choosing to learn about the study and then deciding not to participate would also have no 
impact on their care. Those who were interested were given information about the study in the 
language of their choice (isiZulu or English) by the research assistant (Appendix 4 ).  It was 
made clear that there was no direct personal reward for participating in the project but that it 
was hoped that their participation would lead to better care for all TB patients in the future. 
Those wishing to participate then signed consent (Appendix 5) all the participants accepted the 
offer of being given a written copy of the information leaflet, in some instances saying that they 
would keep it for a family member who could read. Participants were reminded that they could 
withdraw at any time during the study and the distress protocol was explained.  At each 
consecutive interview consent was verbally verified prior to the administration of the APCA 
POS questionnaire (Appendix 6). After completing the fourth consecutive weekly interview the 
research assistant thanked the participant and informed them that she would not be 
interviewing them again the following week.  
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Family members  
Participants were asked to consent to the interview of a family member whom they had 
identified to participate in the study, the family member would then be informed about the study 
and asked to sign consent. . However, because so few family members were available in the 
hospital setting, with only 7 interviews conducted with a family member this data was not 
included in the study.  
 
DATA COLLECTION  
Table 1 on the next page indicates the data that is required for each of the objectives for the 
first phase of the study and the methods for collecting, analyzing and presenting this. 
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TABLE 1: DATA COLLECTION PLAN FOR PHASE 1    
OBJECTIVE METHOD DATA  
To measure the prevalence of multi-
dimensional problems on admission 
Administer APCA POS 
questionnaire within the 
week of admission to 
hospital. 
 
Compile table of 
combined baseline scores 
for each question. 
1. Intensity of pain  
2. Intensity of other symptoms 
3. Level of worry 
4. Ability to share feelings 
5. Feeling of life being worthwhile 
6. Feeling at peace 
7. Enough help and advice for 
family to plan for future 
To conduct an audit of palliative care-
related outcomes to determine whether 
there is a difference in the prevalence 
and intensity in the problems 
experienced between TB and MDR-TB 
patients on entry to the hospital  
Document TB status so 
as to be able to 
differentiate between TB 
and MDR-TB participants.   
 
Compile table showing 
multi-variate analysis for 
total POS score  
As above (all 7 patient-related items 
listed on APCA POS) 
To measure change in problem intensity 
over time 
Conduct APCA POS 
interviews on a weekly 
basis over four 
consecutive weeks. 
 
Indicate the data collected 
at each time period in  
box plot for each APCA 
POS item. 
As above (all 7 patient-related items 
listed on APCA POS) 
Table 1 above shows how the data for the first phase of the study would be collected and how 
it would be analysed and presented. 
Data collection procedure 
Consenting participants were issued with a study number which reflected the week in which 
they were recruited, whether they had TB or MDR-TB and where they fitted into the sequence 
in terms of the required 57 participants for each type of TB. For example study number W4T4 
would indicate that the fourth participant with drug responsive TB had been recruited in week 4 
and W7M3 would show that the third participant with MDR-TB had been recruited in week 7. 
The study number, together with the required demographic information which was obtained 
from the patient record was then entered onto the data collection sheet (Appendix 6). This form 
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was devoid of any personal identification details. A separate form was used for each 
consecutive interview.   
Information regarding Partner/Spouse, Total number of children and Children under 5 years 
old, was self-reported by participants. The remainder of the demographic and medical 
information that was documented was accessed from the participants’ patient records. 
 
Storage of data 
Once the consecutive APCA POS audits had been completed or the participant had withdrawn 
consent or died the forms were collated per participant and kept in a locked container in the 
researcher’s office. The signed consent forms together with the completed APCA POS 
questionnaires are stored in a locked cabinet in the researcher’s office.  Data was entered into 
an Excel spreadsheet on a weekly basis.   
 
Sample 
The sample size of 114 participants was based on 135 TB admissions to Murchison Hospital 
over a three month period. This size sample allowed the prevalence of a single audit indicator 
e.g. pain with a 50% response distribution and comparison of the problems experienced by TB 
and MDR-TB participants at baseline to be detected. It also allowed for the change in intensity 
of symptoms over time to be measured via four weekly interviews. The latter is with reference 
to the Encompass audit baseline POS data of HIV patients (n=413)11 using the physical and 
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psycho-social POS problems, to detect a difference of 2.5 with a standard deviation of 4.13, 
90% power and 5% significance, n = 114.  
Inclusion criteria:  Adult patients, eighteen years and older, with a confirmed diagnosis of TB 
who had been admitted to the hospital during the preceding week. 
Exclusion Criteria:  
1. Children under the age of 18 years 
2. TB patients reported by the professional nurse in charge of the ward, as not being 
cognitively able to respond to the study questions  
3. Patients whom either the professional nurse in the ward or the researchers had considered 
to be too ill to approach with study information.  
No data was collected with regard to the numbers of consecutive patients who fitted these 
exclusion data. 
Prospective primary data was collected from individual participants by conducting a weekly 
audit over a period of four consecutive weeks to determine the palliative care-related outcomes 
in respect of the patient outcome indicators listed on the APCA POS.  
 
Process of data collection  
A separate APCA POS questionnaire containing standardized participant demographic and 
diagnostic variables was used for each interview.  
Once a participant had given informed consent, the first of four consecutive weekly individual 
interviews was conducted. The first interview always took place in the hospital setting in either 
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the TB or MDR-TB ward. The setting for subsequent weekly interviews was dependent upon 
whether the participant was still in hospital, had been transferred to a satellite facility or 
discharged home. With the exception of the first interview which took a little longer, each 
interview took less than 10 minutes. 
 
DATA COLLECTION TOOL   
The African Palliative Care Association African Palliative Outcome Scale (APCA POS), a brief 
multi-dimensional outcome measure using patient and family-level indicators was used to 
collect quantitative audit data. The APCA POS was developed under the auspices of the 
African Palliative Care Association by a multi-professional expert group that included palliative 
care practitioners from South Africa. All answers are scored using Likert scales from 0-5, with 
numerical and descriptive labels. The items address physical and psychological symptoms, 
spiritual and emotional concerns as well as psychosocial needs. The APCA POS form was 
completed by the research assistant who asked each participant the questions listed in     
Figure 1 which follows on the next page. 
 
 
 
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
49 
 
Figure 1: APCA POS Patient Questionnaire 
ASK THE PATIENT POSSIBLE RESPONSES 
Q1. Please rate your pain (from 0 = no pain to 5 = 
worst/overwhelming pain) during the last 3 days 
   0 (no pain)- 5 (worst/overwhelming pain) 
0     1      2      3      4      5   
Q2. Have any other symptoms (e.g. nausea, coughing 
or constipation) been affecting how you feel in 
the last 3 days? 
                  0 (not at all)- 5 (overwhelmingly) 
0     1      2      3      4      5   
Q3. Have you been feeling worried about your illness in 
the past 3 days? 
0 (not at all)- 5 (overwhelming worry) 
0     1      2      3      4      5   
Q4. Over the past 3 days, have you been able to share 
how you are feeling with your family or friends? 
                     0 (not at all)- 5 (yes, I’ve talked freely) 
                 0     1      2      3      4      5   
Q5. Over the past 3 days have you felt that life was 
worthwhile? 
0 (no, not at all)- 5 (yes, all the time) 
0     1      2      3      4      5   
Q6. Over the past 3 days, have you felt at peace?` 0 (no, not at all)- 5 (Yes, all the time) 
0     1      2      3      4      5   
Q7. Have you had enough help and advice for your 
family to plan for the future? 
0 (not at all)- 5 (as much as wanted) 
0     1      2      3      4      5   
 
Only the questions for the patient are included in Figure 1. To view the complete APCA POS 
which includes questions for the family please refer to Appendix 6. 
Validity and Reliability 
In a paper reporting on the full, international multi-centre clinical validation of the APCA POS 
Harding et al noted that an analysis of in-depth qualitative interviews with patients and family 
members had confirmed that the tool had face validity in terms of being appropriate and 
acceptable to the target population. Internal consistency was established with test/re-test 
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reliability indicating the stability of the measure in terms of it being appropriately sensitive to 
change. The validation study concluded that the APCA POS had sound psychometric 
properties and high levels of acceptability in the African clinical setting.11 
During this study the isiZulu and English translations were used according to participant 
preference. Additional demographic and diagnostic data were added to the questionnaire as 
reflected in Appendix 6. 
 
Distress Protocol  
As is routine during the implementation of the APCA POS a distress protocol was put into 
place.  Any participant who had appeared to become distressed would have been offered the 
opportunity to cease the interview and either abandon or restart when they were comfortable to 
do so. The interviewer would have passed on any information to the nurse responsible for their 
care at the patient’s/family’s request and the participant offered counselling from a psycho-
social professional from the local hospice programme. Please refer to the Participant 
Information Leaflet for details. (Appendix 4)  
 
QUANTITATIVE DATA ANALYSIS  
 
All data was entered into Excel and then imported into SPSSV21 for analysis.  
All data were cleaned and checked, and POS items reversed as necessary so that 0=best and 
5=worst score. Baseline data were presented in full with all responses tabulated.  
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First the sample characteristics were analysed using descriptive methods. The response rate 
and completeness of data by time point were also calculated.  
The baseline scores were then presented for each item and response level together with the 
median and inter-quartile range.  
Association with baseline scores was determined using linear regression, with the POS total 
score and factor 1 (physical and psychological problems) as dependent variable for each 
model. Univariate analyses were conducted first followed by multivariable analyses, with 
independent variables significant at 25% level in univariate analyses entered into the 
multivariable model.   
As can be seen in the chapter which follows, the B unstandardised coefficient and its 95% 
confidence interval are presented. For those who participated in every data collection point, 
box plots are presented for several items showing the median and interquartile range.  
The change over time for matched pairs on the entire sample was conducted for each item 
using Wilcoxon signed rank.  
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PHASE 2: 
GENERATING A PALLIATIVE CARE FOCUSED QUALITY IMPROVEMENT STRATEGY 
FROM THE AUDIT FINDINGS. 
OBJECTIVES: 
1. To convene a quality improvement focus group discussion with key members of staff 
selected from the TB care sites in order to use the data from phase 1 to generate a quality 
improvement strategy. 
2. To report on the development of a palliative care-related quality improvement strategy.  
 
1. FOCUS GROUP DISCUSSION (FGD) 
This qualitative method of data collection was selected because of the need to create new 
ways of thinking about palliative care-related quality improvement in a hospital setting. It was 
felt that data collection would be enriched by both the individual contributions members made 
and how these contributions would mix together in a focus group and spark further 
discussion.67   The FGD which was taped, was conducted in English and moderated by the 
researcher who was assisted by an observer skilled in note taking. 
 
Study population 
The study population for phase 2 was the professional health care staff at the Hospital MDR-
TB and TB wards and two satellite facilities. 
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Recruitment 
A purposive sample of 12 participants was invited to attend the FGD at Murchison Hospital on 
28 February, 2013. The persons respectively in charge of the male and female MDR-TB units 
and TB ward at Murchison Hospital were asked to collectively select 10 health care 
professionals with a key role in quality improvement and interest in palliative care, to 
participate in the 90 minute FGD. The senior managers at the two satellite facilities (Genesis 
Care Centre and the Dunstan Farrel TB Hospital) were each invited to select 1 health care 
professional to represent their organisation at the FGD.  
 
Selection Criteria 
Inclusion Criteria: Members of the health care team from the district hospital and/or satellite 
facility who have freely consented to participate in the focus group after reading the detailed 
information sheet which stipulates that internal confidentiality cannot be guaranteed. (Appendix 
7 – FGD Information Leaflet.) 
 
Exclusion Criteria: None 
 
Preparation for the FGD  
Selected participants were issued with invitations which doubled as the FGD participant 
information leaflet three weeks before the event (Appendix 7) together with a copy of the semi-
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structured questionnaire which would be used to guide the FGD (Appendix 8) and a copy of 
the consent form that they would be required to sign (Appendix 9). Because all the potential 
invited participants have hectic schedules, they were reminded of the time and venue of the 
FGD the day before it took place  
 
Observer training 
The FGD Observer was given training on the study design as well as the role of an FGD 
Observer and the ethical considerations that pertain to FGDs. A pilot FGD was then conducted 
at South Coast Hospice during which participants discussed compliance with the criteria 
stipulated in the Quality Improvement Service Element of the Hospice Palliative Care 
Standards.60   The pilot FGD served as practical training for the observer and although it was 
tape recorded, the data is not included in the study. 
 
Ethical considerations 
Informed consent 
To ensure that consent was informed, participants were given an information sheet which 
detailed the ground rules and latent risks associated with participation in a focus group 
(Appendix 9) three weeks before the FGD. While the researcher can give potential participants 
in a focus group the ethical assurance that he/she will safeguard their privacy and keep their 
verbal contributions confidential, this amounts to what Tolich refers to as external 
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confidentiality.  It is not possible to offer internal confidentiality because once the FGD has 
been completed the behavior of other participants is out of the researcher’s control.69   
Participants were assured that they would be free to withdraw at any time despite having given 
signed consent.  
 
Privacy and confidentiality 
Participants would be acknowledged by participant numbers on the tape and their names do 
not appear in the FGD report.  
 
Distress protocol 
The name and contact details of a psycho-social professional from the local hospice who was 
available to provide FGD participants w th debriefing/counselling was included in the 
information leaflet. (Appendix 7) 
 
Procedure used for the FGD 
Seating was arranged in a round table format. On arrival FGD participants were asked to sign 
the attendance register and hand in their signed consent form.(Appendix 9) They were then 
issued with a participant number which they placed on the table in front of their chair. Each 
participant was given a handout (Appendix 10) which explained that the purpose of the 
meeting was to review the summarised audit findings and explore ideas in terms of using these 
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to develop a palliative care-related quality improvement strategy. Two of the invitees sent 
apologies as they were required to attend other meetings and one failed to attend without 
offering any explanation. 75% of the purposive sample of health care professionals invited to 
the FGD (n=9) participated.  
The FGD was conducted in English and moderated by the researcher. FGD participants were 
reminded that an experienced psycho-social professional from the local hospice was available 
in the unlikely event that any participant became distressed and required counselling.  
After introducing herself, the research assistant and FGD observer, the moderator established 
the ground rules which are reflected on the information sheet.(Appendix 7) Members were 
reminded that their input would be taped and asked to state their participant number prior to 
making any verbal contribution.  
The moderator alerted group members when the tape recorder was switched on and recording 
commenced.  
 
Data collection tools and process 
The semi-structured questionnaire (Appendix 8) together with the FGD participant handout 
(Appendix 10) which included a summary of the audit findings were used to guide the 
discussion. In addition to asking the pre-determined questions, the moderator followed up on 
comments by participants.  The observer made notes on the group dynamics and body 
language of the group members , these were used to inform the final FGD report.  
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Before concluding the FGD at the scheduled time the moderator gave participants an 
opportunity to make any final contribution to the discussion. Informal discussion regarding the 
way forward continued for the next 20 minutes over a light lunch. 
2. REPORT ON THE DEVELOPMENT OF A QUALITY IMPROVEMENT STRATEGY 
Analysis of qualitative data 
The researcher typed up the taped FGD verbatim within hours of the event and immersed 
herself in the data . The transcripts were then enhanced by the notes taken by the observer 
with regard to the mood, attitudes and feelings displayed by participants as well as dynamics 
within the group. This formed the basis of the report on the development of a quality 
improvement strategy which is included in Chapter 7. Data analysis was done manually by 
compiling a taxonomy that incorporated the recurrent comments and concepts iterated by FGD 
participants (Table 24). This allowed the data to be focused by topic and organized into 
categories that identified the trends and general themes. Ultimately, relational action codes 
linked to quality improvement activities were created.67, 68 The entire process was 
independently checked and validated by an academic colleague experienced in qualitative 
research and palliative care. 
 
Storage and dissemination of the FGD data 
The digital recording was transcribed verbatim by the researcher who will retain one hard copy 
for five years in a locked cabinet. FGD participants will be sent a summary of the report on the 
development of a quality improvement strategy. 
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CHAPTER 4                                                                              PHASE 1 RESULTS  
________________________________________________________________ 
RESULTS FOR PHASE 1: AN AUDIT OF THE PALLIATIVE CARE-RELATED 
PROBLEMS OF A COHORT OF HOSPITALISED TB PATIENTS 
OBJECTIVES: 
1. To measure the prevalence and intensity of multi-dimensional problems among TB 
patients on admission to the hospital TB and MDR-TB wards 
2. To conduct an audit of palliative care-related outcomes for study participants to 
determine whether there is a difference in the prevalence and intensity in the problems 
experienced between TB and MDR-TB patients on entry to the hospital 
3. To measure change in problem intensity over time (4 x weekly interviews) 
A summary of the quantitative findings of the audit of palliative care-related outcomes using a 
validated outcome measure, the APCA POS are presented in this chapter.  A discussion of the 
results and the research limitations for the first phase of the study follow in the next chapter. 
 
Sample characteristics  
The majority (n=76, 66.7%) were female (missing n=1, 0.9%). The mean age was 33.2 
(SD=10.4, minimum=18 maximum=65). The proportion of respondents who reported having a 
partner was 53.5% (n=61, missing n=5). The vast majority (n=91, 79.8%) had children (with a 
range of 1-7 children). With respect to their TB, 50% (n=57) had a diagnosis of MDRTB. The 
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vast majority had HIV co-infection (n=97, 85.1%). Of those with HIV, n=82 (84.5%) were 
currently on ART, n=13 not (13.4%) (missing n=2). All participants (100%, n=114) were 
currently on TB treatment. Previous TB treatment was reported by 65 respondents (57%), and 
of these n=33 (28.9%) were cured, n=15 (13.2%) completed, n=8 (7.0%) defaulted, and n=8 
(7.0%) failed. Weight in Kg was a mean 51.7)  
Only 58/97 HIV pts had their CD4 recorded.  
 
Other chronic conditions noted on patients file were:  
Diabetis Mellitus – 2 
Chronic Obstructive Airways Disease – 2 
Hypertension – 1 
Epilepsy - 1 
 
Differences between the participants with drug responsive and drug resistant TB are illustrated 
in Table 2 on the following page. Some of the interesting facts that can be seen are that more 
than half of the participants with drug responsive TB and a third of those with MDR-TB had not 
previously been treated for TB. Of those who had previously been treated the cure rate was 
better for the MDR-TB participants even though treatment failure was reported in 5 of these 
participants compared to 3 with drug responsive TB. The overall rate for defaulting on previous 
treatment is relatively low. There is a very high HIV/TB co-infection rate for both groups at 80% 
and 91% respectively. All (100%) of the MDR-TB patients with HIV co-infection were on 
HAART compared to 68% of those with drug responsive TB. More males than females had 
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MDR-TB. Participants with drug resistant TB collectively had more children overall as well as 
more children under the age of 5 years. 
Table 2: Information regarding participants with TB and MDR-TB 
Information TB MDR-TB 
First TB treatment   30 (53%) 19 (33%) 
Previously treated for TB            27 (47%)             38 (67%) 
Cured with previous treatment              8 (14%)             25 (44%) 
Completed previous treatment              9 (16%)              6 (11%) 
Defaulted previous treatment 2 (4%) 6 (11%) 
Previous treatment failed             3 (5%)              5 (9%) 
Co-infected with HIV        45 (80%)     52 (91%) 
On HAART       34 (60%)      50 (88%) 
HIV negative                9 (16%)                 5 (9%) 
HIV status unknown                3 (5%) 0 (0%) 
Males              17 (30%)              21 (37%) 
Females              40 (70%)              36 (63%) 
Average age  35.6             32.7 
Average weight in Kg 48.7             54.5 
Partners         26 (46%)  35 (61%) 
Total number of children 92 108 
Children younger than 5 years 15 22 
Died  5 (9%) 3 (5%) 
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Recruitment  
The full sample n=114 was recruited into the study. 
 
Table 3: Summary of participant recruitment  
Number of potential participants who were given study information 132 
Number who consented to participate in the study 114 
Number of new patients who were too ill to approach 46 
Number who withdrew consent during the course of the study 9 
 
As we can calculate from the table above, the response rate was 86.3%. 
Half the participants (57) had been diagnosed with MDR-TB and the other half with drug 
responsive TB. It took 24 weeks to recruit the 57 participants with drug responsive TB and 32 
weeks to recruit the same number of MDR-TB participants due to a slower rate of admission of 
patients with drug resistant TB. (See Table 4 on the next page) 
MDR-TB had been excluded in the 3 participants with drug responsive TB in whom previous 
TB treatment had failed. All the participants were on TB treatment. Of the 13 who were HIV 
positive and were not currently receiving HAART: 
 9 had been admitted to fast- track ARVs 
 2 had been on ARVS but defaulted and were to be given counseling and education before 
being re-started 
 1 was very recently diagnosed HIV+ 
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 1 was considered to be too ill with TB to be started on HAART although able to answer 
APCA POS questions 
The weight in Kilograms was a mean 51.7. The 10 participants who were not weighed were 
unable to stand on the scale. 
 
Deaths during the data collection period 
As illustrated in the Table 4 below proportionately many more deaths occurred in the TB ward 
than in the MDR-TB section of the hospital. In calculating the percentages 24 weeks was 
considered as 6 months and 32 weeks as 8 months. 
Table 4: Number of deaths  
TB WARD MDR-TB WARDS 
Average monthly admissions             30 
No of deaths during 24 weeks 
of data collection                                 40 
 
Deaths as a % of  admissions                      
22.22%     
Average monthly admissions        15 
No of deaths during 32 weeks 
of data collection                            15 
 
 Deaths as a % of admissions                        
12.5% 
  
As we can see in Table 4 the number of deaths as a % of admissions is almost double in the 
ward catering for people with drug responsive TB compared to the MDR-TB wards. The figures 
reflected in this table include study participants as well as patients who were admitted and died 
during the week between the data collection day and those who were considered to be too ill to 
approach with study information. Table 5 below gives a breakdown with regard to the deaths of 
study participants. 
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Table 5: Deaths of study participants 
Number Age Gender Diagnosis ART CD4 Weight Baseline 
Pain  
Children 
W9T17 35 F TB/HIV YES 29 - 1 1  
W13T29 46 F TB/HIV YES - 50Kg 1 0 
W16T35 25 F TB/HIV YES 9 56Kg 4 2 
W16T36 38 F TB/HIV YES - 42Kg 3 2 
W18T45 32 M TB/HIV NO 33 51Kg 4 2 
W20T51 34 F TB not 
HIV+ve  
N/A N/A 52Kg 3 1 
W20T52 22 F TB/HIV YES - 48Kg 5 1 
W22M32 35 M MDR-TB/HIV YES 49 54Kg 1 0 
W24M37 33 M MDR-TB/HIV YES 480 49Kg 5 2 
 
Table 5 shows that 7 of the 9 participants who died during the study (78%) had been 
diagnosed with drug responsive TB and 6 (67%) were female. Collectively the study partipants 
who died  had 11 children. 89% or 8 of 9 were co-infected with HIV. The only HIV+ participant 
who was not on ART had been admitted to fast track the commencement of anti-retroviral 
treatment. There does not seem to be any correlation between the pain rating on admission to 
the likelihood of death. 
 
 
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
64 
 
Audit interviews 
As illustrated in Table 6  below all 114 participants had one interview, 94 were available for the 
second interview, 79 for the third and 64 had four consecutive weekly interviews.         
Table 6 : APCA POS Interviews  
Participant 
diagnosis 
1st  2nd interview 3rd interview 4th interview TOTAL 
TB 57 43 33 26 159 
MDR-TB 57 51 46 38 192 
 114 94 79 64 351 
 
The attrition rates for each time point calculated from Table 4 above are indicated in Table 7 
below. 
Table 7 : Attrition rate for each consecutive time point 
Participant 
diagnosis 
After 1st  
interview 
After 2nd 
interview 
After 3rd 
interview 
TB 24.5% 23.2% 21.2% 
MDR-TB 10.5% 9.8% 17.3% 
 35% 33% 38.5% 
 
As we can see from Table 7 that the attrition rate was considerably higher in the group with 
drug responsive TB. 
 
Place of interview 
A total of 351 interviews were conducted.  The majority n= 313, (89%) and all of the first 
interviews were conducted at Murchison Hospital, 8 at the Genesis Care Centre and 5 at the 
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Dunstan Farrel TB Hospital. The remaining 25 interviews took place after a participant was 
discharged home. In 2 instances it was possible to visit the home for a face to face interview, 
in the remaining 23 instances the interview was conducted telephonically. 19 participants who 
had been sent home could not be reached and were lost to follow up. More than half of these 
particpants (n=10 or 53%) had three interviews, 5 or 26% had two interviews and the 
remaining 21% were lost to follow up after the first interview. 
 
Withdrawal of consent  
During the course of the study, consent was withdrawn by 9 participants, 9 died and in 3 
instances an enrolled participant was not approached for the next interview because the 
researchers considered the person to be too ill to be disturbed.  Five of the participants who 
withdrew consent had MDR-TB and 4 drug responsive TB. Of the participants who died 6 had 
drug responsive TB and 3 MDR-TB. Of those considered to be too ill to approach for the next 
interview by the researchers 2 had drug responsive TB and 1 MDR-TB. 
Distress protocol 
Although they were made aware of the distress protocol, this was not required by any of the 
participants during the course of the first phase of the study. 
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Interview questions 
The APCA POS audit form showing the questions which participants were asked for four 
consecutive weeks is replicated below as a reminder to the reader, as each of the items will be 
reported on later in this chapter. 
Replica of Figure 1: APCA POS Patient Questionnaire 
ASK THE PATIENT POSSIBLE RESPONSES 
Q1. Please rate your pain (from 0 = no pain to 5 = 
worst/overwhelming pain) during the last 3 days 
   0 (no pain)- 5 (worst/overwhelming pain) 
0     1      2      3      4      5   
Q2. Have any other symptoms (e.g. nausea, coughing 
or constipation) been affecting how you feel in 
the last 3 days? 
                  0 (not at all)- 5 (overwhelmingly) 
0     1      2      3      4      5   
Q3. Have you been feeling worried about your illness in 
the past 3 days? 
0 (not at all)- 5 (overwhelming worry) 
0     1      2      3      4      5   
Q4. Over the past 3 days, have you been able to share 
how you are feeling with your family or friends? 
                     0 (not at all)- 5 (yes, I’ve talked freely) 
                 0     1      2      3      4      5   
Q5. Over the past 3 days have you felt that life was 
worthwhile? 
0 (no, not at all)- 5 (yes, all the time) 
0     1      2      3      4      5   
Q6. Over the past 3 days, have you felt at peace?` 0 (no, not at all)- 5 (Yes, all the time) 
0     1      2      3      4      5   
Q7. Have you had enough help and advice for your 
family to plan for the future? 
0 (not at all)- 5 (as much as wanted) 
0     1      2      3      4      5   
 
Only the APCA POS questions for the patient are shown in Figure 1. To see the questions for 
family members please refer to Appendix 6. 
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Measurement of the prevalence of multi-dimensional problems experienced by TB 
patients on admission to hospital: 
Table 8 below shows the baseline data for the full sample of participants on admission to the 
hospital. Baseline data are presented in full with all responses tabulated together with the 
median and interquartile range scores. All data were cleaned and checked, and POS items 
reversed as necessary so that 0=best and 5=worst score. 
Table 8: Baseline APCA African POS scores for full sample of patients with drug 
responsive and drug resistant TB  
 0 (Best 
status) 
n (%) 
1 
 
n (%) 
2 
 
n (%) 
3 
 
n (%) 
4 
 
n (%) 
5 (worst 
status) 
n (%) 
Median 
(IQR) 
Pain 11(9.6) 14 (12.3) 20 (17.5) 21 (18.4) 20 (17.5) 28 (24.6) 3.0 
(2.00-
4.25) 
Symptoms 7 (6.1) 7 (6.1) 14 (12.3) 51 (44.7) 23 (20.2) 10 (8.8) 3.0 
(2.25-4.0) 
Worry  7 (6.1) 5 (4.4) 9 (7.9) 24 (21.1) 33 (28.9) 36 (31.6) 4.0  
(3-5) 
Life 
worthwhile 
32 (28.1) 33 (28.9) 22 (19.3) 7 (6.1) 3(2.6) 17 (14.9) 1.0  
(0-2) 
Share 
feelings 
12 (10.50 22 (19.3) 29 (25.4) 11 (9.6) 15 (3.2) 25 (21.9) 2.0  
(1-4) 
At peace 10 (8.8) 30 (26.3) 57 (50.0) 12 (10.5) 4 (3.5) 1 (0.9) 2.0  
(1-2) 
Help/advice* 24 (21.1) 24 (21.1) 19 (16.7) 4 (3.5) 5 (4.4) 35 (30.7) 2.0  
(1-5) 
Note re missing data: n=3 with regard to help/advice in planning for the future and symptom rating n=2 
It is clear from Table 8 that the predominant problems experienced by participants on 
admission to hospital related to pain, symptoms and worry. The majority of the participants had 
severe pain on admission with a quarter rating their pain as 5 which equates to the worst 
imaginable or overwhelming pain. Over 80% of participants rated their symptoms at 3, 
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indicating that it was moderate to severe, or higher. The table also shows that the worst score 
was in relation to how worried participants felt about their illness.  
Fifteen participants rated both their pain and worry as overwhelming with a score of 5 for both 
these items at baseline. As shown in Table 9 on the next page two thirds of these participants 
had MDR-TB, the majority were female and co-infected with HIV and ten had children under 5 
years old. This will be elaborated on in the discussion which follows.  
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TABLE 9: PARTICIPANTS WITH OVERWHELMING PAIN AND WORRY ON ADMISSION  
Type of TB Gender  Age Children 
 (under 5yrs) 
HIV status TB Rx history 
MDR-TB Female 33 3 (1) HIV+ on ART Completed Rx 
MDR-TB Female 38 3 (1) HIV+ on ART  Previous TB cured 
MDR-TB Male 21 1 (1) HIV negative 1st TB Rx 
MDR-TB Female 39 3 (1) HIV+ on ART 1st TB Rx 
TB Female 38 4 (1) HIV+ on ART Defaulted  
TB Female 48 - HIV negative 1st TB Rx 
TB Female  28 2 (1) HIV negative 1st TB Rx 
e 85.MDR-TB Female 65 5 HIV+ on ART Defaulted 
MDR-TB Male 23 (1) HIV+ on ART Previous TB cured 
TB Female 24 0 HIV+ on ART Previous TB cured 
TB Male 19 0 HIV negative 1st TB Rx 
MDR-TB Female 31 (1) HIV+ on ART Previous TB cured 
MDR-TB F 62 1 HIV+ on ART Completed TB Rx  
MDR-TB F  30 (1) HIV on ART Completed TB Rx 
MDR-TB F 25 3 (2) HIV+ on ART Defaulted 
 
The characteristics of the participants reflected in Table 9 are discussed on page 85. 
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The last four APCA POS questions concerning feeling that life is worthwhile, ability to share 
feelings, having a sense of peace and sufficient help and advice to plan for the future, scored 
well compared to the first three. 
 
Differentiation of TB and MDR-TB problems on admission 
Audit to differentiate the prevalence and intensity of palliative care-related problems 
experienced between TB and MDR-TB patients on entry to hospital. 
Table 10 on the next page shows univariate associations with the POS total score, and POS 
factors at baseline. Association with baseline scores was determined using linear regression, 
with the POS total score and factor 1 (physical and psychological problems) as the dependent 
variable for each model.. This is followed by Table 10 which shows the multivariate analyses, 
for total POS score with age and gender entered into the model.  
It can be seen from Tables 8 and 10 that older patients and patients whose TB is NOT drug 
resistant have the worst total POS score for  Factor 1 (physical and psychological problems) 
worse problems are associated with TB that is NOT drug resistant.  
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Table 10: Univariate association with the POS total score, and POS factors at baseline 
Independent 
variables  
 Outcomes (dependent) 
  POS total  
B (95% CI) 
p 
Factor 1 
Physical & 
psychological  
  
Age  B=0.112 
(0.032, 0.191) 
p=0.006 
B=0.046 
(-0.011, 0.104) 
p=0.115 
  
Gender  B=-0.308   
(-2.136, 1.519) 
p=0.739 
B=-0.840 
(-2.127, 0.446) 
p=0.198 
  
Drug 
resistance  
 B=1.764 
(0.100, 3.428) 
p=0.038 
B=1.697  
(0.535, 2.859) 
P=0.005 
  
Partner or not   B=-0.291  
(-2.040, 1.458) 
p=0.742  
B=-0.320 
(-1.562, 0.922) 
p=0.611 
  
Prior 
treatment  
 B=-0.057 
(-0.851, 0.462) 
p=0.558 
B=-0.040 
(-0.510, 0.429) 
p=0.865 
  
Weight   B=0.020  
(-0.062, 0.102) 
p=0.635 
B=0.054 
(-0.003, 0.110) 
p=0.063 
  
 
Table 11: Multivariate analyses for total POS score 
Independent 
variables  
 Outcomes (dependent) 
  POS total  
B (95% CI) 
p 
Factor 1 
Physical & 
psychological  
  
Age  B=0.113 
(0.035, 0.191) 
p=0.005 
B=0.041 
(-0.024, 0.106) 
p=0.214 
  
Gender  - B=-0.502 
(-1.801, 0.797) 
p=0.445 
  
Drug 
resistance  
 B=1.797 
(0.187, 3.408) 
P=0.029 
B=1.997 
(0.761, 3.234) 
p=0.002 
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Measurement of change in problem intensity experienced over time. 
The graphs that follow show the mean score attained for each of the APCA POS criteria 
disaggregated by participant diagnosis of drug responsive or drug resistant TB (TB or MDR-
TB). It should be noted that in these graphs the POS items are represented in their original 
format and have not been reversed. The lowest score is therefore best for the first three 
questions e.g. 0=no pain and 5 = worst possible pain. Whereas for questions 4, 5, 6 and 7 the 
best score is the highest in that for example 0= never at peace and 5 = always at peace. In 
each of these graphs the first interview shows the rating for the specific problem participants 
experienced on admission to the hospital. The next three interviews indicate change in the 
problem intensity over the following three weeks. 
As will be seen, the predominant problems experienced by both groups of participants were 
worry, pain and symptoms.  
It is also evident that the burden of pain, symptoms and worry was highest in the participants 
diagnosed with drug responsive TB. 
Box plots and a table showing an analysis of the pain, symptoms and worry experienced by 
participants are included here.  
 
 
 
 
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
73 
 
Figure 2: Mean scores for pain 
 
 
It is clear from Figure2 above that the mean score for pain was higher (worse) for the 
participants with drug responsive TB. 
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Figure 3: Pain over time 
 
The Figure 3 box plot shows us that for the 62 patients who completed every time point, pain 
did not seem to show any sustained change, with the median changing between 3 and 2 then 
back to three and returning to 2. The IQR ends up between 1 and 4. 
The non-parametric analysis of change for the full sample is shown in Table 12 below.  
 
 
 
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
75 
 
Table 12: Non-parametric analysis of change with regard to pain 
Pain  Median Wilcoxon 
signed 
rank 
comparing 
to 
previous 
time point 
Z score 
P value 
T1 n=114 3   
T2 n=92 3 -1.917 0.06 
T3 n=77 3 -0.055 0.96 
T4 n=63 2 -1.410 0.159 
 
Table 12 shows that while between T1 and T2 there was a borderline statistically significant 
change between T1 and T2, there was no significant change in pain during the data collection 
period. It should be noted that, on a pain scale of 0-5, the median remains in the top half of the 
scale.  
Figure 4: Mean scores for symptoms 
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We can see from Figure 4 that the symptoms experienced by participants with drug responsive 
TB in this cohort of hospitalised patients were more severe than those experienced by 
participants with MDR-TB. 
 
Symptoms over time  
From Figure 5 we can see that for the 62 patients who completed symptoms at all the time 
points the median score remains around 3. 
Figure 5: Symptoms over time 
 
The non-parametric analysis of change regarding symptoms is shown in Table 13 below.  
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Table 13: Non-parametric analysis of change in symptoms 
Symptoms  Median Wilcoxon 
signed 
rank 
comparing 
to 
previous 
time point 
Z score 
P value  
T1 n=112 3   
T2 n=90 3 -1.590 0.112 
T3 n=76 2 -1.814 0.070 
T4 n=62 3 -1.176 0.240 
 
Table 13 above shows that while there was a borderline significant change between T2 and T3 
at no point was the change significant at the 5% level.  
 
Figure 6: Mean scores for worry 
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We can see from Figure 6 that the participants with drug responsive TB experienced more 
worry than those with MDR-TB at each time point. 
 
Figure 7: Worry over time 
 
Figure 7 shows us the high level of worry experienced by participants on admission and how 
this improved by week 2. 
 
For the entire sample, the non-parametric analysis of change with regard to worry is shown in 
Table 14 on the next page. 
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Table 14: Non-parametric analysis of change in worry 
Worry  Median Wilcoxon 
signed 
rank 
comparing 
to 
previous 
time point 
Z score 
P value  
T1 n=114 4   
T2 n=93 2 -4.144 0.001 
T3 n=76 2 -0.186 0.853 
T4 n=63 2 -0.535 0.593 
 
Table 14 shows us that, while a statistically significant reduction in worry happens by T2, this 
does not change any further.  
 
Figure 8: Mean scores for ability to share feelings
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Figure 8 on the previous page tells us that there was no real difference in the ability that 
participants from both groups had to share how they were feeling with family or friends. 
 
Figure 9: Mean scores for feeling that life is worthwhile
 
We can see from Figure 9 that participants with MDR-TB felt that life was more worthwhile 
than those with drug respo sive TB. Although the scores relating to feeling that life was 
worthwhile were not as serious as those for pain, symptoms and worry the matched analysis is 
depicted in Table 15 because this item worsened after the first time point. 
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Table 15: Matched analysis of life worthwhile  
Feeling life 
worthwhile   
Median Wilcoxon 
signed 
rank 
comparing 
to 
previous 
time point 
Z score 
P value  
T1 n=114 1   
T2 n=93 2 -3.785 0.001 
T3 n=77 2 -1.047 0.295 
T4 n=63 2 -0.455 0.649 
 
We can see in Table 15 above that over time feeling that life was worthwhile actually worsened 
by a statistically significant margin by the second visit then did not change significantly.   
Figure 10: Mean scores for feeling at peace 
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Figure 10 above shows us that the score for feeling at peace went up and down for both 
groups of participants. At the fourth week after the initial interview the participants with MDR-
TB scored best for this item.  
Figure11: Mean scores for help and advice in planning for the future 
 
Figure 11 above shows that there is very little difference between the two groups of 
participants regarding the question ‘Have you had enough help and advice for your family to 
plan for the future.’  There is an improvement by the 4th week but this is not statistically 
significant. 
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Predictors of attrition  
In order to determine whether those lost to follow-up had different problem intensity compared 
to those who remained in the study, the total POS score and POS items for those who had 
interviews at all 4 time points and those who did not was compared.  No statistically significant 
difference was found in the two groups.  
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 CHAPTER 5:       DISCUSSION OF PHASE 1 RESULTS 
________________________________________________________________ 
DISCUSSION OF PHASE 1 RESULTS 
 
AN AUDIT OF THE PALLIATIVE CARE-RELATED PROBLEMS EXPERIENCED BY A 
COHORT OF HOSPITALISED TB PATIENTS 
In this section the results presented in Chapter 4 are discussed and expanded upon in relation 
to the available literature and the study objectives for the first phase of the study. 
 OBJECTIVES OF PHASE 1 
1. To measure the prevalence and intensity of multi-dimensional problems among TB patients 
on admission to the hospital TB and MDR-TB wards. 
2. To conduct an audit of palliative care-related outcomes for study participants to determine 
whether there is a difference in the prevalence and intensity in the problems experienced 
between TB and MDR-TB patients on entry to the hospital. 
3. To measure change in problem intensity over time (4 x weekly interviews). 
 
Study participants 
An additional 5 weeks (29) was required to recruit the same number of MDR-TB participants 
(57) compared to participants with drug responsive TB (24 weeks). This is linked to the longer 
length of stay in hospital by patients with MDR-TB that results in fewer admissions. On 
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average the time spent in hospital in the MDR-TB wards is 66 days, compared to 22 days in 
the TB Ward. 
The greater proportion of females with MDR-TB (61.4%) is in keeping with findings of a 
retrospective record review of patients with MDR-TB in Durban in 2011.30  This may well be 
linked to the high TB/HIV co-infection rate in the sample as, in this country, the incidence of 
HIV is higher in women than in men.6 In Africa, HIV is the single most important contributing 
factor to the escalating TB epidemic3  and according to the WHO Global Tuberculosis Report 
for 2012, ‘TB is one of the top killers of women.’2 
In this study 79.8% of the participants were parents who collectively had 200 children, 42 of 
whom were younger than 5 years old. These children become extremely vulnerable when 
orphaned. Traditional African models of surrogate care can no longer accommodate the sheer 
numbers of orphaned children brought about by the AIDS pandemic.70   . The APCA POS 
baseline score showed that 84% of participants with children younger than 5 years (n=25) 
rated their worry between 3 and 5. Table 12 shows that of the 15 participants who rated both 
their pain and worry as 5 i.e. overwhelming, 12 (80%) had children and 10 (67%) had children 
under the age of 5 years. It is therefore probable that concern about their children contributed 
significantly to the worry experienced by participants 
 
MDR-TB 
Stigma, together with a legitimate fear of contracting TB71 is prevalent among health care 
workers who may be inclined to lay the blame of the MDR-TB crisis on defaulting patients.13, 14 
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It is therefore worth emphasizing that only 6 participants or 10.5% of the sample of MDR-TB 
participants in this study had defaulted on their previous TB treatment.  
A third of the sample of participants with MDR-TB (19/57) in this study had never been treated 
for TB before. This is consistent with findings from a postmortem study conducted at a public 
hospital in KZN, where 16% of patients who died from MDR-TB did so during their first ever 
course of TB therapy72. It is likely that these patients were primarily infected with MDR-TB. 
The high level of poverty in the rural area served by the hospital, together with a TB/HIV co-
infection rate of 82.5% would seem to indicate that there was an impressive commitment to a 
difficult treatment protocol by the majority of the MDR-TB participants. Many of these people 
live in a challenging environment. 
 
Deaths  
An unexpected finding was that almost three times as many deaths occurred in the TB ward 
(40) compared to the MDR-TB wards (15) as indicated in Table 4 in the previous chapter. This 
does, however, need to be considered within the context of drug responsive TB being 
predominantly managed in the community. As a result, only patients with severe problems 
and/or advanced illness are admitted to the limited number of beds in the ‘ordinary’ TB ward. 
Therefore the fact that this study was limited to participants admitted to hospital does to a 
degree, account for this finding.  It is, however, alarmingly similar to findings from the 
postmortem study mentioned above, in which 70% of the patients who died from TB while 
receiving treatment, had drug responsive TB.72 The expectation is that patients with drug 
responsive TB who are on treatment will be cured. 
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Prevalence and intensity of problems on admission to hospital 
 
Measurement of the prevalence and intensity of multi-dimensional problems among TB 
patients on admission to the hospital TB and MDR-TB wards. 
 
Table 8 in the previous section indicated a high score with regard to patients experiencing 
worry, pain and symptoms on admission to the hospital. The least problems were associated 
with the sharing of feelings, being at peace and feeling that life was worthwhile. The latter may 
seem strange given the findings regarding the high burden of pain/ symptoms and worry. 
There could be a connection between this apparent anomaly and the fact that the vast majority 
of the sample population comprised rural Africans. The research assistant who grew up in the 
area suggested that rural communities have the ability to retain a sense of peace even in the 
face of severe suffering. In any event the way people perceive quality of life is affected by 
culture73 and can be influenced by both experience and expectations.74 
 
Differentiation of problems of TB and MDR-TB patients on admission 
 
An audit of palliative care outcomes for study participants to determine whether there is 
a difference in the prevalence and intensity in the problems experienced between TB 
and MDR-TB patients on entry to the hospital. 
 
The graphs depicted in Figures 2, 4 and 6 in the previous chapter, indicate that patients with 
both TB and MDR-TB experienced significant physical and psychological problems on 
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admission to hospital.  This finding confirms what current literature asserts regarding the need 
for palliative care in drug-resistant TB.12, 17  
Significant problems associated with drug responsive TB  
The fact that the overall POS scores were higher for participants who did not have MDR-TB, 
however, provides substantial new information regarding the extensive palliative care-related 
needs of patients with drug responsive TB. This could be linked to the higher death rate for this 
group as well as the finding that participants with MDR-TB found life to be more worthwhile 
than those with drug responsive TB. 
 In their report entitled Groundbreaking meeting on MDR and XDR TB and palliative care, the 
World Wide Palliative Care Alliance mentions that palliative care is rarely included in guidelines 
and policies relating to the treatment and care of MDR and XDR patients.75 No mention is 
made of drug responsive TB which was not on the agenda of the consultative meeting 
regarding palliative care and TB held in Geneva in November, 2010. The challenge now, is for 
‘ordinary’ drug responsive TB to be included in this type of communication within both palliative 
care and TB circles. 
 
Change in problem intensity over time 
Measurement of change in problem intensity over time (4 x weekly interviews) 
Pain 
It is clear from Figure 2 that the pain experienced by participants did not show any significant 
change over time. The median level of pain changed between 3 and 2 and then went back  
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to 3. This suggests that the hospital staff have not considered pain to be a priority within the 
context of TB disease or the side effects of treatment.29, 30 It therefore follows that  
hospital doctors and nurses would benefit from the pain control aspects of palliative care 
training.18  
 
Symptoms  
The same applies to the management of symptoms as can be seen in Figure 5. The median 
score for symptoms also moves from 3 to 2 and then back to 3. The predominant symptoms 
were cough, nausea and constipation. Although no specific prompt was given with regard to 
dyspnoea this was not generally apparent to the researchers.   
The APCA POS is administered by a health care professional. Participants volunteer the 
symptoms, but as can be seen from Figure 1, cough, nausea, vomiting and constipation are 
listed as potential prompts for the interviewer.  Consideration could be given to adding 
dyspnoea to this list of potential symptoms when using it with a population of TB patient.  
Adapted symptom versions of the POS have been used in other specific patient groups.47  
 
Palliative care-related audit findings 
The audit findings regarding pain and symptoms resonate with a statement made within the 
context of MDR-TB which asserts that the alleviation of suffering associated with disease and 
its management has been restricted mostly, but not adequately to physical aspects.12  The 
participant’s patient records/clinical notes perused during this study focused on demographics, 
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medical history, nutritional and treatment issues. The management of pain and symptoms 
were seldom prominent in the participants’ patient records.   
Psychological problems 
As shown in Table 8 and Figures 6 & 7, on admission to hospital the entire sample 
experienced a substantial amount of worry. The median rating for worry was 4. Some of this 
may have been associated with fears about hospitalization in that the median score was 
statistically significantly reduced by the second week to 2, after which there was no further 
change.   The vast majority of the 15 participants who had overwhelming pain and worry on 
admission were females with MDR-TB who had young children at home, this is likely to have 
significantly contributed to their worry.(Table 9, pg 69) .  
No mention of worry was found in any of the patient records perused during the study. The fact 
that patients and families affected by life threatening illness face difficulties which span 
physical, emotional, social and physical aspects is well documented in the literature.5,15,19 
Palliative care training includes a focus on communication regarding the honest sharing of 
sensitive and frightening information.15, 12The best outcome scores were attained with regard to 
the questions regarding the ability to share feelings, being at peace and having sufficient help 
and advice to plan for the future. This finding contrasts with an in depth qualitative study 
conducted in palliative care programmes in South Africa and Uganda that found that 
‘individuals in Africa with progressive incurable disease need better information and 
communication about their disease and its management’.76     
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Promoting cure via care 
A focus on the provision of more holistic care could be a key issue in improving TB treatment 
outcomes. The latter notion is supported by an MDR-TB programme run by Medecins Sans 
Frontiers in Khayelitsha in which a patient-centred decentralized model of care increased case 
finding and improved treatment outcomes thereby reducing further MDR-TB transmission.40   
Psychosocial support has been acknowledged as an important element in the management of 
adverse events related to TB treatment. Education, counseling and encouragement can all 
contribute towards achieving successful patient outcomes in terms of treatment adherence.33     
Optimal care for those with HIV disease continues to be a priority alongside prevention and 
treatment. The provision of HIV/AIDS medical care that focused solely on the technical 
elements of HAART would be detrimental to both patients and carers.24, 25   It is strongly 
suggested that this point of view is as applicable within the context of TB.   
 
Attrition 
The overall rate of attrition was 21% (24/114).  Nine participants withdrew consent (7.8%) 
during the course of the study. Five did so because they felt too ill to be interviewed.  Three 
decided they no longer wished to participate in the study for no apparent reason, and one who 
was a traditional healer, because she had embarked upon a spiritual ritual during which she 
was not permitted to speak about herself. A further 9 participants died and in 3 instances an 
enrolled participant was not approached for the next interview because the researchers 
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considered the person to be too ill to be disturbed. It can be projected that the participants who 
died or were too ill to continue with the study would have benefitted from palliative care-related 
interventions.44   A comparison of the total POS scores between participants who had all four 
weekly interview and those who did not showed no statistically significant difference.  It can 
therefore be presumed that the same symptom intensity was experienced by the group that 
was lost to follow up.  
Summary of key findings The key findings with regard to the data gathered during phase 1 
are summarized in Figure 12.  
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Figure 12: Summary of key findings of phase 1 (APCA POS audit) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The predominant palliative care-related problems experienced by all 
participants on admission to hospital were worry, pain and symptoms 
 
The burden of pain, physical symptoms and worry was highest in participants 
with drug responsive TB 
 
Nearly three times as many deaths occurred in the ward for drug responsive TB 
(40) as in the MDR-TB wards (15) during the data collection period  
 
One third of the MDR-TB participants (19/57) had not previously been treated 
for TB and probably contracted MDR-TB as their primary infection 
 
Only 10.5% (6/57) of MDR-TB participants had defaulted on previous treatment 
 
There was no significant sustained change in the level of pain and symptoms 
experienced by participants over four consecutive weekly audit interviews 
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RESEARCH LIMITATIONS REGARDING PHASE 1 
 
1. .Because the vast majority of the audit interviews took place in the hospital setting for the 
most part family members were not available to participate.  The 7 family member 
interviews that were conducted were not included in the data analysis. 
2. Due to the logistical problems associated with following up participants discharged from 
hospital it was often not possible to conduct face to face interviews, 19 interviews were 
therefore conducted telephonically. This could introduce bias in that privacy could not be 
guaranteed. 
3. The APCA POS was used in its original form and did not include a prompt in respect of 
dyspnoea. It is therefore possible that this important TB symptom was not fully captured 
during the audit process. 
4. Data collected on the number of new patients too ill to approach was regretfully not 
disaggregated by diagnosis of TB or MDR-TB or gender and this information is therefore 
unavailable. 
5. This study was limited to auditing the palliative care-related problems experienced by 
hospitalised patients with drug responsive TB, whilst the vast majority of these patients are 
managed in the community. The study sample can therefore not be considered to be 
representative of the broader TB patient population. 
6. Although data was collected on the number of children under 5 years, no information was 
obtained with regard to what was done for this high risk group. 
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CHAPTER 6                                                                                           PHASE 2 RESULTS 
________________________________________________________________ 
 
PHASE 2 RESULTS  
 
GENERATING A PALLIATIVE CARE FOCUSED QUALITY IMPROVEMENT STRATEGY 
FROM THE AUDIT FINDINGS. 
OBJECTIVES: 
1. To convene a quality improvement focus group discussion with key members of staff 
selected from the TB care sites in order to use the data from phase 1 to generate a 
quality improvement strategy. 
2. To report on the development of a palliative care-related quality improvement strategy.  
 
The qualitative findings from the focus group discussion (FGD) during which the audit results 
were reviewed with the aim of generating a palliative care-related quality improvement 
strategy, are presented in this section. These are followed by a report on the quality 
improvement strategy agreed to by the FGD participants. 
 
Recruitment  
A purposive sample of 12 health care professionals was invited to attend the FGD in the Board 
Room of Murchison Hospital. N=9, (75%) of the sample participated. 
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Description of participants 
The 9 participants comprised: 
 the 3 professional nurse managers in charge of the respective male and female MDR-
TB units and the TB ward  
 the clinical manager from the Genesis Care Centre one of two satellite sites where 
some of the audit interviews were conducted 
 the hospital CEO 
 the TB matron 
 the medical doctor from the TB ward  
 the person responsible for overseeing quality improvement in the hospital 
 one professional nurse from the TB ward  
 
Themes and codes emerging from FGD 
The researcher and an independent academic colleague agreed that the following four themes 
captured the essence of the FGD: 
1. Understanding of palliative care 
2. Pain within the context of TB 
3. Worry experienced by hospitalised TB patients 
4. Building on existing quality improvement (QI) initiatives and additional 
opportunities identified for enhancing palliative care-related patient outcomes. 
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The numbered codes* below indicate the actions identified as being required to match the 
specified participant input.  
Palliative care training *1  
Collaboration with the local hospice and other NGOs*2 
Specific QI initiatives*3 
Table 16 below illustrates the above by capturing participant comments and suggestions under 
a selected theme together with the relevant action oriented code. Participant comments are 
reflected under a specific theme although they may fit with more than one. 
 
 Table 16: Summary of FGD aimed at generating palliative care-related QI  
Theme Input from FGD participants  Identified 
action code 
Understanding 
of palliative 
care (pc) 
 
 
 
‘Giving up on a patient as a Dr, or stepping back’ 
 
‘pc should not be considered as the point of giving up but rather 
the starting point of giving total care and promoting hope in TB 
patients and their families’ 
 
‘I thought pc was applied when cure was no longer an option 
and the patient was kept comfortable and given holistic care so 
that they could die in peace and with dignity’ 
 
1*; 2* 
 
 
1*; 2* 
 
 
 
1* 
 
Pain within the 
context of TB 
 
 
 
 
 
 
 
 
 
‘TB is not considered to be a painful condition, why do patients 
have pain?’ 
 
‘MDR-TB patients often have severe chest pain when large 
cavities are present. There are often also side effects of TB 
medication like peripheral neuropathy. The MDR section started 
a garden project which did not work because the patients’ feet 
were too painful for them to be able to participate’  
 
African patients don’t complain of pain unless specifically asked 
and nurses should probe and be proactive regarding this’ 
 
1* 
 
 
 
1*; 3* 
 
 
 
 
1* 3* 
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Pain within the 
context of TB 
(continued) 
‘could anything be done to improve pain experienced by 
emaciated TB patients related to daily intramuscular injections?’ 
 
‘important to reflect pain in care plan and use a measuring tool 
or pain scale’ 
 
‘important to re-assess pain after analgesia is prescribed’  
 
‘we should include a discussion on pain in the recently 
introduced weekly ward round’ 
 
2* 
 
 
3* 
 
3* 
 
 
3* 
Worry 
experienced 
by 
hospitalised 
TB patients  
‘patients in the TB ward usually have advanced illness and dire 
social circumstances, the TB ward should screen all admissions 
with a view to facilitating grants as is done in the MDR section’ 
 
‘we should consider the high level of worry as a wake-up call 
and have the social worker see all the patients’ 
 
‘it is important for the team to have their communication skills 
improved, it is difficult to get alongside a patient to enable them 
to talk about what is really worrying them’ 
 
‘whole team needs pc training including communication skills’ 
 
‘Patients in hospital worry about their families at home’ 
 
3* 
 
 
3* 
 
 
1* 
 
 
 
1* 
 
2* 3* 
 
 
 
Building on 
existing QI 
initiatives and 
additional 
opportunities 
identified for 
enhancing pc-
related patient 
outcomes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
‘ start with pc training for Drs so that they prescribe medication in 
line with WHO analgesic ladder. As a pc trained nurse I am not 
comfortable telling Drs what to prescribe’  
 
‘all team members need pc training, not only Drs they all need to 
focus on pain management and holistic care’ 
 
‘it would be good to increase liaison with the local hospice 
especially Dr to Dr as it would be more acceptable for our Drs to 
take advice from another medical Dr’ 
 
‘ Consider pain as a vital sign’ 
 
‘Appoint a pain nurse in each of the TB wards and consider pain 
as important as infection control’ 
 
‘get into the habit of assessing pain regularly and add a pain 
scale to the patient records’ 
 
 
‘Explore ways of facilitating contact between hospitalised MDR-
TB patients and their families at home with a view to reducing 
their worry, ensure that this thought is pursued with the 
upcoming MDR-TB partnership with South Coast Hospice’ 
 
 
1* 
 
 
1* 3* 
 
 
 
 
2* 
 
 
3* 
 
3* 
 
 
3* 
 
 
 
2* 3* 
 
 
2* 3* 
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Building on 
existing QI 
initiatives and 
additional 
opportunities 
identified for 
enhancing pc-
related patient 
outcomes 
(continued) 
‘in relation to the MDR-TB partnership, perhaps a staff exchange 
programme could be arranged with the hospice so that staff from 
the MDR-TB wards work in their in-patient unit for a few days to 
learn pc while hospice staff work in the MDR-TB wards to learn 
more about MDR-TB 
 
‘ we can reflect pain in the care plan and put a pain scale in the 
records straight away’ 
 
‘Appointing one nurse in the ward as the person responsible for 
reminding the whole team of pain’ 
 
 
‘Arrange pc training for Drs and the rest of the team’ 
 
 
3* 
 
 
 
3* 
 
 
 
1*, 2* 
 
 
1* 
 
The key contributions made by the participants in the FGD are reproduced in the taxonomy 
(Table 16) above. 
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CHAPTER 7               DISCUSSION OF PHASE 2 RESULTS 
________________________________________________________________ 
 
DISCUSSION OF PHASE 2 RESULTS 
 
GENERATING A PALLIATIVE CARE - FOCUSED QUALITY IMPROVEMENT STRATEGY 
FROM THE AUDIT FINDINGS. 
The following two objectives will be respectively reported on in the first and second section of 
this chapter. 
OBJECTIVES: 
1. To convene a quality improvement focus group discussion with key members of staff 
selected from the TB care sites in order to use the data from phase 1 to generate a 
quality improvement strategy. 
 
2. To report on the development of a palliative care-related quality improvement strategy.  
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SECTION 1 
FGD aimed at generating a quality improvement strategy. 
It is worth noting that the participating professionals who comprised 75% of the purposive 
sample who had been invited to the FGD were representative and included senior people who 
have the authority to make decisions. They were all already involved in quality improvement 
(QI) and had demonstrated an interest in palliative care-related issues. This is in keeping with 
a simple FGD Interview definition ‘An interview with a group of individuals assembled to 
discuss a given topic’.77  The group were given the opportunity to focus their discussion on a 
topic in which they were interested.78 
The FGD summary portrayed in Table 14 in the section above gives an indication of the frank 
and open discussion that took place. All the participants made valuable contributions and 
seemed to be at ease with one another. 
The purpose of data analysis is to organize, provide structure to, and elicit meaning from 
research data. In qualitative data analysis this involves the identification of themes and 
concepts. 79, 80    
The first 3 themes that emerged from the FGD transcript were: 
understanding of palliative care; 
 pain within the context of TB; 
 worry experienced by hospitalised TB patients.  
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These together with each of the linked action codes of palliative care training; collaboration 
with the local hospice and other NGOs and specific QI initiatives informed the quality 
improvement strategy. They are summed up in the fourth theme that equates with the QI 
strategy developed by the FGD participants viz. Building on existing QI initiatives and 
additional opportunities identified for enhancing palliative care –related patient 
outcomes. 
 
SECTION 2 
The development of a palliative-care related quality improvement strategy. 
As well as a number of specific QI initiatives the palliative care-related QI strategy developed 
during the FGD at Murchison Hospital prioritized the identified actions related to palliative care 
training and enhanced collaboration with HPCA, South Coast Hospice and other NGOs in the 
area, as cross cutting issues.  
 
CROSS CUTTING ISSUES 
Palliative care training  
Arranging for initial palliative care training for the entire team was considered to be an 
important foundational step which would be followed up with in-service training on the topic. 
The latter would be ensured by including a palliative care slot on the In-service Training 
Register. Besides the need for training related to pain and symptom management, teaching on 
communication skills was considered to be a prerequisite in terms of addressing the main QI 
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indications arising from the APCA POS audit. As one participant said ‘it is difficult to get 
alongside a patient to enable them to talk about what is really worrying them’. This is made 
more difficult by the perception that the need to wear a N95 respirator whenever there is direct 
contact with a potentially infectious patient presents a barrier to sensitive communication.  
The poignant comment by another participant regarding the inability of MDR-TB patients to 
participate in a garden project ‘because their feet were too painful’ highlights the need for 
training to include the management of pain and symptoms related to the side effects of 
treatment. The question/comment ‘why do TB patients have pain, it is not considered to be a 
painful condition’ underscores a widely held misconception as well as the need for a training 
focus on pain within the context of TB.  
 
Provision of holistic care 
FGD participants recognized the need for a more holistic approach to care. To quote a 
participant from the ordinary TB ward ‘we should consider the high level of worry in our 
patients as a wake-up call and have the social worker screen all patients on admission.’’ A 
professional nurse in charge of one of the MDR-TB wards mentioned how ‘patients in hospital 
worry about their families at home’ and went on to say how this would be exacerbated by the 
extended time period currently spent in hospital by MDR-TB patients.  This is of particular 
significance when one considers that 66% of the sample who participated in the first phase of 
the study was female and that there were more females n=35 than males n=22 in the MDR-TB 
sample.  In general, African women are probably more inclined to worry about home than their 
male counterparts. In addition only 53.5% of the sample reported having a partner although 
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they collectively described having 200 children, 42 of whom were younger than 5 years old. 
The latter statement raises real concerns about the apparent disconnect between hospital and 
home given that this group of children with immature immune systems are at particular risk of 
contracting TB.66 
Enhanced collaboration 
A person from the FGD was nominated to approach South Coast Hospice to request palliative 
care training for the Drs, nurses and social workers working in the TB and MDR-TB section of 
the hospital. In the words of one participant, ‘it should start with palliative care training for the 
Drs so that they prescribe medication in line with the WHO analgesic ladder. As a palliative 
care trained nurse I am not used to or comfortable about telling Drs what to prescribe.’ This 
concept was endorsed by another participant who said ‘it would be good to increase liaison 
with the local hospice especially Dr to Dr as it would be more acceptable for our Drs to take 
advice from another medical Dr.’ 
 
Potential future plans 
By the time the FGD took place the effect of the faster and more accurate diagnosis of MDR-
TB brought about by the introduction of GeneXpert81   was already having a serious impact on 
bed availability for these patients.  A Dr at the hospital informed the researcher that there had 
been as many new cases of MDR-TB diagnosed within the first three months of 2013 as there 
had been for the whole of 2012. This crisis had prompted preliminary negotiations with HPCA 
and South Coast Hospice with regard to the establishment of a specific formal networking 
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arrangement that would allow selected MDR-TB patients who would normally be hospitalised 
to receive home based care.  
During the FGD several suggestions were made with regard to this pending arrangement.  
These included ‘explore including the possibility of facilitating contact between hospitalised 
MDR-TB patients with their families at home’ and ‘perhaps a staff exchange programme could 
be arranged so that staff from the MDR-TB wards work in the hospice in-patient unit for a few 
days to learn more about palliative care while hospice staff work in the MDR-TB wards to learn 
more about caring for people with drug resistant TB’.  
 
Track record 
The excellent track record that exists between these organisations bodes well for the 
implementation of both of these valuable and innovative ideas.82   The former would be likely to 
reduce the high level of worry experienced by hospitalised TB patients and the latter could 
prove to be a mutually beneficial practice-based learning opportunity. It is not inconceivable 
that in the process networking would be further enhanced and potentially lead to further 
benefits for TB patients and their families. 
 
Specific QI initiatives aimed at improving palliative care-related patient 
outcomes 
In this section bullet points that represent the way forward are presented under the three 
themes that comprise the palliative care-related QI strategy. 
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Understanding of palliative care 
 Introductory palliative care training for Drs, nurses and social workers 
 Six-monthly in-service training on a relevant palliative care-related topic 
 Explore the possibility of more professionals including at least one medical Dr getting a 
recognised qualification in palliative care 
Managing pain within the context of TB 
 Appoint a ‘pain nurse’ in each of the TB wards and make him/her responsible for 
reminding the whole team of pain and ensure that it is included in the weekly ward 
round discussion 
 Consider pain as a vital sign and ensure that it is reflected in the care plan 
 Include a pain scale in the patient records 
 Document the regular re-assessment of pain after the prescription of analgesia. 
 
Worry experienced by hospitalised TB patients 
 Social worker to screen all admissions to the TB ward with a view to facilitating grants 
as is already done in the MDR-TB section 
 Improve communication skills through palliative care training to enhance sensitive 
communication that will allow hospitalised patients to talk about their fears and worries 
 Pursue the exploration of facilitating communication between hospitalised TB patients 
and their families, particularly young children, at home 
 
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
107 
 
Limitations of the study with regard to Phase 2 (Using the audit data to 
generate palliative care-related quality improvement) 
 
Despite the high number of deaths that occurred during the study period, end of life care which 
remains an important part of palliative care, was not deliberated during the FGD. 
 
This study was limited to the identification of a QI strategy and did not assess its 
implementation or the impact it had on improving palliative care related patient outcomes. 
 
Due to the fact that there was no audit data available for children and adolescents under 18 
years, the palliative care-related needs of this group were not included in the FGD. 
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CHAPTER 8                         CONCLUSION AND RECOMMENDATIONS 
___________________________________________________________________________ 
 
CONCLUSION AND RECOMMENDATIONS 
 
Overview  
This multiple methods longitudinal study was divided into two phases.  During the first phase, 
the prevalence and intensity of the multi-dimensional physical, social, emotional and spiritual 
problems of a cohort of hospitalized TB patients in a rural District Hospital in KwaZulu-Natal 
were identified and measured.  A validated outcome measurement tool, the APCA POS 
(Appendix 6) was used for this purpose. The audits took place on a weekly basis over four 
consecutive weeks. The study sample comprised 114 participants half of whom had been 
diagnosed with drug responsive TB and half with MDR-TB.  
During the second phase of the study, the data obtained from this audit were reviewed by key 
staff members in a focus group discussion (FGD) meeting. The aim of the FGD was to use the 
audit findings to generate a palliative care-focused quality improvement strategy.   
 
Phase 1 findings 
The baseline APCA POS scores showed that both groups of TB patients, those with drug 
responsive TB and those with drug resistant TB had significant physical symptoms including 
pain, cough and nausea. Over 80% were co-infected with HIV.  Many of the 55 patients who 
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died during the data collection period were bread winners and had left small children behind. 
The worst audit scores were attained with regard to pain, symptoms and worry.  
An important and unanticipated finding was that patients with drug responsive TB who were 
admitted to hospital experienced more severe physical and emotional palliative care-related 
problems than those with drug resistant TB. 
There was no sustained statistically significant change in the intensity of problems experienced 
by the participants over four consecutive weekly interviews. 
It is evident that a comprehensive approach of good palliative care with a focus on the whole 
person is needed for all TB patients. 
 
Personal reflection 
On a personal level I have grappled with the ethical dilemma of relinquishing the role of 
palliative care nurse in order to fulfill the role of researcher. Identifying serious palliative care-
related problems in TB patients and then not trying to influence any intervention to address 
their suffering because they were participants in my study does not feel right. This pertains 
particularly to pain, is it ethical to measure pain and then do nothing about controlling it? Can 
this passive acceptance of unnecessary suffering in 114 research participants be justifiable if it 
leads to better care for many more people with TB? 
This dilemma highlights the issue that palliative care and the relief of pain ought to be 
universally recognised as a human right.83   
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Value of the APCA POS 
The full intrinsic value of the APCA POS as a validated outcome measure can only be 
achieved when it is linked to improving clinical care. It is therefore imperative that audit findings 
are linked to quality improvement. As mentioned in the literature review, audit should be seen 
as the process of reviewing the delivery of care to identify deficiencies so that they may be 
remedied 41, 42 
 
Phase 2 findings 
The themes which emerged from the FGD as issues that needed to be addressed were:  
 Understanding of palliative care; 
 Pain within the context of TB;  
 Worry experienced by hospitalised TB patients  
 Building on the existing quality improvement (QI) infrastructure. 
 
 A palliative care-related QI strategy was developed with the aim of improving pain and 
symptom control and addressing the fears of TB patients. This comprised palliative care 
training, a focus on the identification and management of pain and plans to ameliorate the level 
of worry experienced by hospitalised TB patients.  
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Recommendations for further research 
1. Assess the impact of the QI strategy developed during this study on patient care by a 
repeat APCA POS audit within the next 6-12 months 
2. Conduct similar studies of linking APCA POS audits to quality improvement in additional 
hospital settings 
3. Conduct a community-based  assessment of the palliative care-related problems 
experienced by people with drug responsive TB and their primary caregivers/family 
members 
4. Conduct a study to investigate how much support and prophylactic TB intervention is 
provided to the families of hospitalised TB patients, particularly children under 5 years old 
5. Evaluate the impact of palliative care training given to all cadres of hospital staff caring for 
patients with drug responsive and MDR-TB 
6. Conduct a similar study to assess the problems experienced by children with TB by using 
the paediatric version of the APCA POS, as soon as the validation process for this outcome 
measurement tool has been completed 
7. Consider adding dyspnoea to the list of symptoms mentioned on the APCA POS form when 
it is used in the TB context. 
8. Evaluate the impact of partnerships between palliative care programmes and hospitals 
providing care to patients with drug responsive and MDR-TB 
9. Assess the impact of a comprehensive palliative care approach on TB treatment outcomes.  
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Policy related recommendations  
 The provision of palliative care should be explicitly included in policies and guidelines 
relating to the care of people with both drug responsive and drug resistant TB 
 Conduct audits of the palliative care-related needs of hospitalised TB patients linked to 
quality improvement initiatives at least once a year 
 Stimulate partnerships between palliative care programmes and hospitals providing care to 
patients with drug responsive and MDR-TB 
 Facilitate palliative care training for all cadres of hospital staff providing care to patients with 
drug responsive and MDR-TB 
 
CONCLUSION 
Palliative care within the context of TB is still an emerging concept. This study makes a 
meaningful contribution to the scarce information currently available. The topic is of great 
importance in that the suffering experienced by vast numbers of TB patients and their families 
could and should be substantially relieved. 5   This study has identified the need for a 
comprehensive palliative care person-centred approach in this patient population.  As such it 
has responded to the request for the evidence called for in the literature.10, 12, 17, 52, 64   It is 
hoped that the linking of audit findings to quality improvement within the context of TB will 
stimulate similar research and ultimately lead to consistent improved patient care. As such it 
will support the existing Guidelines for Providing Palliative Care to Patients with Tuberculosis.5    
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It is hoped that national and international policy makers will take cognizance of these findings 
and give due consideration to the explicit inclusion of palliative care in all TB related policies 
and guidelines.  
Funding that is made available to stimulate the provision of palliative care training and delivery 
in the context of TB could have considerable impact in terms of relieving unnecessary suffering 
and promoting better treatment outcomes. 
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UNIVERSITY OF C\PE TOWN 
14 May 2012 
HREC REF: 220/2012 
Mrs Kathleen Defilippi 
c/o Dr L Gwyther 
Family Medicine 
Falmouth Bldg 
FHs 
Dear Mrs Defilippi 
Faculty of Health Sciences 
Faculty of Health Sciences Research Ethics Committee 
Room E52-24 Groote Schuur Hospital Old Main Building 
Observatory 7925 
Telephone (021)406 6338 • Facsimile (021)406 6411 
e-mail: sumayah.ariefdien@uct.ac.za 
~ .. 
PROJECT TITLE: AN EVALUATION OF THE PALLIATIVE CARE OUTCOMES OF TB PATIENTS IN A DISTRICT HOSPITAL 
SETTING: A MULTIPLE METHODS QUALITY IMPROVEMENT STUDY 
Thank you for submitting your study to the Faculty of Health Sciences HUman Research Ethics Committee for 
review. 
It is a pleasure to inform you that the Ethics Committee has formally approved the above-mentioned study. 
Approval is granted for one year till the 28 May 2013. 
Please submit a progress form, using the standardised Annual Report Form (FHS016), if the study contin ues 
beyond the approval period. Please submit a Standard Closure form (FHS010)if the study is completed within the 
approval period. 
Please note the reviewer's comments: 
The protocol is very well written, the researcher certainly seem to have the relevant experience both clinically and 
research related, the setting is in a District Hospital which has pioneered palliative care and the overall risk to 
participants is minimal and well explained in the information sheet. Our recommendation is that someone other 
than the research assistant should be available to communicate in a language other than English about questions 
related to the project (see Appendix 1). Participants in the focus group discussion (Appendix 4) should similarly 
have access to the researchers, and this information should be contained on the information leaflet. The details 
of the Human Research Ethics Committee should be added to both information leaflets. 
Please note that the ongoing ethical conduct of the study remains the responsibility of the prinCipal investigator. 
Please quote the REC. REF in all your correspondence. 
sAriefdien 
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hrec/ref;220/2012 
Yours sincerely 
PROFESSOR M BLOCK MAN 
CHAIRPERSON, HSF HUMAN ETHICS 
Federal Wide Assurance Number: FWA00001637. 
Institutional Review Board (IRB) number: IRB00001938 
This serves to confirm that the University of Cape Town Research Ethics Committee complies to the Ethics 
Standards for Clinical Research with a new drug in patients, based on the Medical Research Council (MRC-SAj, 
Food and Drug Administration (FDA-USA), International Convention on Harmonisati n Good Clinical Practice (ICH 
GCP) and Oeciaration of Helsinki guidelines. 
The Research Ethics Committee granting this approval is in compliance with the ICH Harmonised Tripartite 
Guidelines E6: Note for Guidance on Good Clinical Practice (CPMP/ICH/135/95) and FDA Code Federal Regulation 
Part 50, 56 and 312. 
sAncfdicn 
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health 
Dt!p<lrtmtmt: 
Health 
PROVINCE OF KWAZU LU-NATAL 
Dear Ms K Oefilippi 
Health Research & Knowledge Management sub-component 
10- 103 Natalia Building. :0130 langalib<lle le S~et 
Private Bag ><90 51 
Pietermari lzburg 
3200 
Tel.' 033 - 39531 B9 
Fa~ : 033 - 394 37S2 
Ema,!,: It 
, 
Reference ; HRKM69 / 12 
Enquiri"$ : Mrs G Khumalo 
Telephone: 033 - 395 2805 
28 May 2012 
Subject: Approval o f a Research Proposal 
1, The .esearch proposal titled 'An evaluation o f Ihe palliative care outcomes of a 
cohort of T8 patients in a district hospital setting: A multiple methods qualitv 
Improvements study' \"las reviewed by the KWilZulu-Nala l Department of Health. 
The proposa l is hereby approved for research to be undertaken at Murchison and Dunstan 
Farrell 1'8 Hospitals. 
2 . You are requested to take note of the follow ing. 
a. Make the necessary arrangement with the identified lacilit~ b efore commencin g with 
~our research project. 
b. Provide an interim progress report and f inal report (electronic and hard copies) w hen 
~our research is complete. 
J Your linal report must be posted 10 HEALTH RESEARCH AND KNOWLEDGE 
MANAGEMENT, 10. 102, PRIVATE BAG X9051, PIETERMARITZBURG, 3200 an d e-
mail an electronic copy to httm@kz.nhealth.govza 
For an~ addiTional inlonnation please contact Mrs G Khum alo on 033-395 3189. 
YQUrS Sincerely 
Dr E Lutg 
C hairperson, Health Research Committee 
KwaZulu-Natal Department of Health 
Dale: ~f/tr./LOI ~ . 
~Mnyango we:;:empilo oepartement van Ge:;ondM :d 
Flg/.llrog Disease. Fig/oling PoverTy. GivI"g Hope 
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Postal & Street Address: 
P.O. Box 1099, 
Port shepstone 4240, 
KwaZulu Natal, South Africa 
Lot 17, Izotsha Road, 
Marburg, Port Shepstone 
Kwazulu Natal 
THE NORWEGIAN SETTLERS CHURCH 
COMMUNITY OUTREACH PROGRAMME 
Telephone Numbers: 
Genesis Trust: +27 (0)39 685 4104 
Genesis Care Centre: +27 (0)39 685 7010 
Genesis Youth: +27 (0)39 685 5155 
Genesis Fax: +27 (0)39 685 6976 
Website: www.genesishope.co.za 
Trust Number: IT 1550/ 02 Public Benefit Organisation Number: 930000242 
Attention: To Whom It May Concern 
University of Cape Town 
Cape Town 
Dear Sir/Madam 
Monday 30 April 2012 
RE: AN EVALUATION OF THE PALLIATIVE CARE OUTCOMES OF A COHORT OF TB PATIENTS IN A 
DISTRICT HOSPITAL SETIING : A MULTIPLE METHODS QUALITY IMPROVEMENT STUDY 
We herewith grant permission for a research survey to be conducted by Ms Kath Defilippi at the Genesis Care 
Centre. 
This study will take the form of a weekly audit over a period of four consecutive weeks to explore the 
development of a quality improvement strategy. 
Yours sincerely 
SHARON JONES 
Operations Manager 
Genesis Care Centre 
Trustees - T E Skorpen (Chairman), Pastor T H Downham, Pastor N J Ndovela, 
T J Barratt, Dr G Booyens, N Retief, H Allison , W R Boucher, L C J Kloppers 
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APPENDIX 4 
INFORMATION LEAFLET FOR PEOPLE PARTICIPATING IN THE PALLIATIVE CARE AUDIT 
 AN EVALUATION OF THE PALLIATIVE CARE OUTCOMES OF TB PATIENTS IN A HOSPITAL SETTING: 
 
You are invited to participate in this research project which is being conducted by Kath Defilippi, she has many 
years of experience in palliative care and is now studying for a MPhil palliative medicine degree at the University 
of Cape Town. The study aim is to evaluate how the care received by hospitalised TB patients affects their 
quality of life. Hospitalised TB patients will be asked the same set of questions once a week for four consecutive 
weeks by this research assistant, a palliative care trained person from South Coast Hospice who is fluent in 
isiZulu.  If you leave the hospital before the four weeks have been completed, if it is possible you will be visited 
at your new address to get your answers to the questions for the full four weeks. The researcher may, however, 
decide to withdraw you from the study for this or any other unforseen circumstance that would make your 
continued participation problematic. With the exception of the first interview which make take a little longer, 
each session will take less than 10 minutes.  There are 10 questions, the first 7 are for the person with TB to 
answer and the last 3 for a family member if they are available. You are welcome to ask the research assistant 
any further questions about this project, or if you wish to SMS Kath Defilippi directly on 0784564606 she will 
phone you back but will, unfortunately, only be able to answer questions in English. 
There is no direct personal benefit to you for participating in this study. However, once all the answers to the 
questions from all the participants have been analysed, a meeting will be held with the relevant people at the 
hospital to discuss how best to use the information gained from all the completed questionnaires to produce a 
palliative care quality improvement strategy that could benefit many people with TB in the future. 
You are welcome to think about this and/or discuss it with your friends or family before freely making a decision 
about accepting the invitation to participate or not. If you do decide to be part of this study you will be asked to 
sign a consent form. You will, however, still be free to withdraw at any time without this in any way influencing 
your care.  No personal details will appear on any of the research forms and nobody will know what your 
answers to the questions were except the research assistant who is explaining the study to you.. The Hospice 
Palliative Care Association of South Africa (HPCA) will be reimbursing South Coast Hospice for her time and 
travel costs.  
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In the unlikely event of you finding the questions upsetting, you can stop the interview at any time. The research 
assistant would also be able to arrange for you to receive counselling, from a qualified person from South Coast 
Hospice, if you so wish.  
Thank you for taking the time to read this or listening while it was explained to you by the research 
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APPENDIX 5 
CONSENT FORM FOR PARTICIPATION IN PALLIATIVE CARE AUDIT 
STUDY TITLE: AN EVALUATION OF THE PALLIATIVE CARE OUTCOMES OF TB PATIENTS IN A DISTRICT HOSPITAL 
SETTING: A MULTIPLE METHODS QUALITY IMPROVEMENT STUDY 
 
DATE: 
I confirm that I have been informed about the above study being conducted by Kath Defilippi. 
I have also received, read (or had explained to me), and understood the study as explained in the 
Participant Information Leaflet. 
I understand that my personal details (any identifying information) will be kept strictly confidential. 
I understand that I may, at any stage, withdraw my consent and participation in the study without any 
questions being asked and that I will continue to receive appropriate standard care. 
I have had sufficient opportunity to ask questions and am prepared to participate in the study. 
 
SIGNATURE OF PARTICIPANT:                  DATE: 
SIGNATURE OF INDEPENDENT WITNESS:                                                           DATE: 
 
-------------------------------------------------------------------------------------------------------------------------- 
THIS SECTION IS TO BE COMPLETED BY RESEARCH ASSISTANT 
I have explained the above research protocol and am confident that this consent is informed and has 
been given freely. 
Name of participant:  
SIGNATURE: 
DATE: 
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APPENDIX 6: APCA AFRICAN POS TB PATIENT AUDIT FORM 
DATE: CONFIRMED DIAGNOSIS:  tick one INTERVIEW SETTING: tick 
STUDY NUMBER:  PTB                 M HOSPITAL  
PARTICIPANT AGE:  MDR-TB                  SATELLITE DF 
PARTNER/SPOUSE: YES  /  NO  tick ON TB Rx: YES  /  NO       tick one SATELLITE G 
TOTAL NUMBER CHILDREN:    1ST LINE Rx HOME 
CHILDREN UNDER 5 YEARS:     2nd LINE Rx HIV +:  YES  /  NO    tick one 
GENDER: MALE / FEMALE   tick one    REPEAT TB Rx:  YES  /  NO  ART: YES   /  NO     tick one 
ADDITIONAL COMMENTS: RESULT OF PREVIOUS TB Rx:  tick CD 4 Count: 
    CURED  WEIGHT: 
    COMPLETED  
    FAILED  
                     POS no 1st    2nd    3rd    4th 
ASK THE PATIENT POSSIBLE RESPONSES 
Q1. Please rate your pain (from 0 = no pain to 5 = 
worst/overwhelming pain) during the last 3 days 
   0 (no pain)- 5 (worst/overwhelming pain) 
0     1      2      3      4      5   
Q2. Have any other symptoms (e.g. nausea, coughing 
or constipation) been affecting how you feel in 
the last 3 days? 
                  0 (not at all)- 5 (overwhelmingly) 
0     1      2      3      4      5   
Q3. Have you been feeling worried about your illness in 
the past 3 days? 
0 (not at all)- 5 (overwhelming worry) 
0     1      2      3      4      5   
Q4. Over the past 3 days, have you been able to share 
how you are feeling with your family or friends? 
0 (not at all)- 5 (yes, I’ve talked freely) 
                 0     1      2      3      4      5   
Q5. Over the past 3 days have you felt that life was 
worthwhile? 
0 (no, not at all)- 5 (yes, all the time) 
0     1      2      3      4      5   
Q6. Over the past 3 days, have you felt at peace?` 0 (no, not at all)- 5 (Yes, all the time) 
0     1      2      3      4      5   
Q7. Have you had enough help and advice for your 
family to plan for the future? 
0 (not at all)- 5 (as much as wanted) 
0     1      2      3      4      5   
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ASK THE FAMILY CARER 
Q8. How much information have you and your family 
been given? 
0 (none)- 5 (as much as wanted) 
N/A  
0     1      2      3      4      5   
Q9. How confident does the family feel caring for 
____? 
0 (not at all)- 5 (very confident) 
N/A  
0     1      2      3      4      5   
Q10. Has the family been feeling worried about the 
client over the last 3 days? 
0 (not at all)- 5 (severe worry) 
N/A  
0     1      2      3      4      5   
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APPENDIX 7 
INFORMATION LEAFLET FOR FOCUS GROUP DISCUSSION PARTICIPANTS 
You are invited to participate in a focus group discussion which forms part of a research project which is being 
conducted by Kath Defilippi, she has many years of experience in palliative care and is now studying for a MPhil 
palliative medicine degree at the University of Cape Town. The aim of the study is to use the data from an audit 
of the palliative care outcomes in hospitalised TB patients to generate a quality improvement strategy. A 
representative sample of hospitalised TB patients will be asked the questions as set out on the APCA POS 
(African Palliative Care Association Palliative Outcome Scale)  which has been validated as an audit tool suitable 
for use in Africa, and translated into isiZulu. The APCA POS will be administered to participants who have freely 
consented to participate in the study, once a week for four consecutive weeks by the research assistant, a 
palliative care trained person from South Coast Hospice who is fluent in isiZulu.  As you will see from the 
attached APCA POS  questionnaire there are 10 questions, the first 7 are for the person with TB to answer and 
the last 3 for a family member if they are available.  
A maximum of 12 consenting members of the health care team will participate in a focus group interview which 
will be conducted in English and moderated by the researcher. During the allotted 90 minutes the group will 
review the analysis of the APCA POS audit findings and share ideas about how this data could be used to 
generate a strategy to improve the quality of palliative care given to hospitalised TB patients. The attached semi-
structured questionnaire will be used to guide the focus group discussion.  
Focus group members will be asked to commit to ground rules that emphasise  listening with respect to the 
opinions of others; keeping the discussion relevant in terms of the intended outcome;  allowing all participants 
to contribute to the discussion and to keeping  these individual discussions confidential. The researcher can give 
you the ethical assurance that she will safeguard our privacy and keep your audio-taped verbal contributions 
confidential she cannot, however, control the behaviour of other group members once the focus group 
discussion has been concluded. By giving your consent you agree to accept this risk inherent to focus groups.  
There is no direct personal benefit to you for participating in this study. However, by generating and 
implementing a palliative care quality improvement strategy based upon the audit data you have the potential 
of contributing to improving the quality of palliative care given to many people with TB in the future.  
You are welcome to think about this before freely making a decision about accepting the invitation to participate 
in the focus group or not. If you do decide to be part of this study you will be asked to sign a consent form. You 
will, however, still be free to withdraw from the focus group discussion at any time. The moderator could also 
ask you to leave the focus group if she deems your participation to be problematic. If you have any questions 
you would like to discuss please feel free to phone or send a text message to Kath Defilippi on 0784564606. 
In the unlikely event of you finding the questions upsetting, you may request debriefing from a psychosocial 
professional from South Coast Hospice by phoning 039-692301 and asking for Dominique Burton or by e-mailing 
dominique@schospice.co.za  
Thank you for taking the time to read this information leaflet.   
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APPENDIX 8 
 
 
FOCUS GROUP DISCUSSION MEETING 
 
Semi- structured Questionnaire 
What does the term palliative care mean to you?         
How have you been involved with Quality Improvement activities?      
Based upon the audit findings, how you would prioritize palliative care quality improvement 
opportunities for TB patients?          
    
What are the most important things that would need to be considered in the formulation of a QI 
strategy to enhance the delivery of palliative care-related activities in your setting?                 
      
How could this concept of a palliative care-related QI strategy be taken forward?                                  
   
Do you have any further comments pertaining to the topic?                                  
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APPENDIX 9 
 
CONSENT FORM FOR PARTICIPATION IN A TAPE RECORDED FOCUS GROUP DISCUSSION 
STUDY TITLE: AN EVALUATION OF THE PALLIATIVE CARE OUTCOMES OF TB PATIENTS IN A DISTRICT HOSPITAL 
SETTING: A MULTIPLE METHODS QUALITY IMPROVEMENT STUDY 
DATE: 
I confirm that I have been informed about the above study being conducted by Kath Defilippi. 
I have also received, and understood the Participant Information Leaflet and realise that the focus 
group discussion will be recorded on a tape recorder. 
I understand that my personal details will be kept strictly confidential by the researcher but that 
confidentiality cannot be absolutely guaranteed in a focus group setting, as indicated in the participant 
information leaflet. 
I understand that I may, at any stage, withdraw my consent and participation without any questions 
being asked. 
I have had sufficient opportunity to ask questions and am prepared to participate in the focus group 
discussion with the intended outcome of generating a palliative care quality improvement strategy for 
TB patients. I am available to attend this focus group discussion in the Board Room at Murchison 
Hospital on Thursday 28 February from 11.30-13.00 after which light refreshments will be served.  
 
SIGNATURE OF PARTICIPANT:                  DATE: 
 
SIGNATURE OF INDEPENDENT WITNESS:                                                           DATE 
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APPENDIX 10 
 FGD HANDOUT 
AN EVALUATION OF THE PALLIATIVE CARE-RELATED OUTCOMES OF A COHORT OF TB PATIENTS IN A DISTRICT  
HOSPITAL SETTING: A MULTIPLE METHODS QUALITY IMPROVEMENT STUDY 
 
 This study was divided into two phases. A measurement of the palliative care –related 
problems experienced by hospitalized TB patients admitted to the Hospital formed the focus of 
the first phase.  A validated outcome tool, the APCA (African Palliative Care Association) 
African POS (Palliative Outcome Scale) was used for this purpose. This brief multi-dimensional 
outcome measure uses patient and family-level indicators that could be used in the routine 
clinical practice, is based upon the WHO definition of palliative care. Prevalence and intensity 
of the multi-dimensional physical, social, emotional and spiritual problems of hospitalized TB 
patients in the TB and MDR-TB wards were identified and measured on a weekly basis for four 
consecutive weeks. The vast majority of the audit interviews were conducted in isiZulu by Sr 
Francisca Dladla who is an experienced palliative care trained professional nurse.   
The full sample of 114 participants was recruited into the study, 57 from the MDR-TB wards 
and 57 from the TB ward. We would like to thank all concerned particularly Sr Singh, Mr 
Ngobese and Sr Memela for the hospitality and co-operation extended to us during the 32 
weeks of data collection.  
Study information was given to 132 participants, 24 declined to participate and the remainder 
signed consent. During the 32 weeks of data collection 46 patients were considered to be too 
ill and were not approached and 9 withdrew consent following at least one interview. A total of 
351 interviews were conducted, 313 or 89% at Murchison Hospital, 8 at Genesis Care Centre 
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and 5 at Dunstan Farrel TB Hospital,  the remainder took place in the patient’s home after 
discharge. In 19 instances we were unable to reach patients who had been discharged home. 
An unexpected finding was that pain and symptoms were marginally worse in patients who did 
not have MDR-TB and that fewer deaths (15) were reported in the MDR-TB wards than the TB 
ward (40). 
The purpose of today’s meeting is to review the audit findings and explore your ideas 
regarding the potential of linking these findings to the development of a palliative care-related 
quality improvement strategy. This forms the second phase of the study. 
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APPENDIX 11 - FGD INTERVIEW GUIDE 
 
Objectives 
1. To identify quality improvement activities to improve the quality of care for TB patients based upon the 
audit findings. 
2. To explore the generation of a quality improvement strategy with hospital and satellite staff.  
Introduction  
Thank everyone for coming and check that they have all given signed consent  
Remind the group of the purpose of the FGD as per the objectives and mention that there are extra copies of a 
summary of the audit findings available in case anyone forgot to bring their copy.  
 Introduce Moderator and Observer 
 Review ground rules and remind everyone to mention their participant number before answering questions  
State that taping will now commence. 
Please tell me about your individual roles and responsibilities?           10 mins   
                           
Semi- structured Questionnaire 
What does the term palliative care mean to you?     10 mins  
How have you been involved with Quality Improvement activities?     
 10 mins 
Based upon the audit findings, how you would prioritize palliative care quality improvement opportunities for TB 
patients?          15 mins 
What are the most important things that would need to be considered in the formulation of a QI strategy to 
enhance the delivery of palliative care in your setting?                   15 mins  
How could this concept of a palliative care QI strategy be taken forward?                                15 mins 
Closure 
Do you have any further comments pertaining to the topic?                         15 mins 
Thank you for your participation, the FGD is now closed. Please help yourselves to refreshments. 
